The Role of Intercellular Communication in Cytotoxic Drug Resistance by Bradley, Christopher
THE ROLE OF INTERCELLULAR COMMUNICATION 
IN CYTOTOXIC DRUG RESISTANCE
by
Christopher Bradley
being a thesis submitted for the degree of 
Doctor of Medicine 
in the
University of Glasgow 
Department of Medical Oncology
May 1992
i
ProQuest Number: 11007643
All rights reserved
INFORMATION TO ALL USERS 
The quality of this reproduction is dependent upon the quality of the copy submitted.
In the unlikely event that the author did not send a com p le te  manuscript 
and there are missing pages, these will be noted. Also, if material had to be removed,
a note will indicate the deletion.
uest
ProQuest 11007643
Published by ProQuest LLC(2018). Copyright of the Dissertation is held by the Author.
All rights reserved.
This work is protected against unauthorized copying under Title 17, United States C ode
Microform Edition © ProQuest LLC.
ProQuest LLC.
789 East Eisenhower Parkway 
P.O. Box 1346 
Ann Arbor, Ml 48106- 1346
GLASGOW 1 
UNIVERSITY I 
l ib r a r y  I
-& -C S JW , j
TABLE OF CONTENTS
page
Table of contents ii
Acknowledgements ix
Index of figures x
Index of tables xii
Abbreviations xiii
Summary xiv
Chapter 1 - INTRODUCTION 1
1.1. Heterogeneity of cellular and tissue function. 1
1.1.1. Heterogeneity of normal cellular function. 1
1.1.2. Cell-cell communication. 1
1.1.3. Tumour cell heterogeneity. 2
1.1.4. Interaction of tumour subpopulations. 3
1.2. The Gap Junction. 5
1.2.1. Metabolic cooperation. 5
1.2.2. Gap junction structure. 5
1.2.3. Junctional permeability. 7
1.2.4. Detection and function of gap junctions. 9
1.2.5. The role of gap junctions in malignancy. 11
1.3. Tumour Spheroids and contact resistance. 12
1.3.1. Spheroids and radioresistance. 12
1.3.2. The influence of spheroid microenviroment
on response. 14
1.3.3. Intercellular communication and contact
resistance. 16
ii
1.3.4. In vivo models of contact resistance. 18
1.3.5. Spheroid resistance to cytotoxic drugs. 19
1.4. Intercellular Communication and Lvmphokine 
Response. 22
1.5. Mechanisms of Cvtotoxic Drug Resistance. 23
1.5.1. Inherent and aquired resistance. 23
1.5.2. The multidrug resistant phenotype. 25
1.5.3. P-glycoprotein. 26
1.5.4. P-glycoprotein as an efflux pump. 27
1.5.5. The mdr gene family. 28
1.5.6. Clinical relevance of mdrl gene and
P-glycoprotein. 2 9
1.5.7. Exocytosis as a drug efflux mechanism. 30
1.5.8. Evidence for other resistance mechanisms. 32
1.5.9. Glutathione and related enzymes. 34
1.5.10. Topoisomerases. 35
1.6. Resistance Models. 36
1.6.1. MDR and clinical response. 36
1.6.2. Prediction of drug response. 38
1.7. Interaction of Sensitive and Resistant Cells. 39
1.7.1. Transfer of drug resistance. 39
1.7.2. Transfer of drug sensitivity. 41
1.7.3. Junctional communication in interactions. 42
1.7.4. A model of interaction between sensitive and
MDR cell lines. 44
1.8. Summary and Objectives. 46
iii
Chapter 2 - MATERIALS AND METHODS. 48
2.1. Materials. 48
2.1.1. Radiochemicals. 48
2.1.2. Drugs. 48
2.1.3. Fluorescent dyes. 48
2.1.4. Chemicals. 48
2.1.5. Tissue culture media. 49
2.1.6. Tissue culture dishes. 49
2.1.7. Cell lines. 50
2.1.8. Vectors for DNA transfection. 51
2.1.9. Solutions. 51
2.2. Tissue Culture Methods. 52
2.2.1. NSCLC lines. 52
2.2.2. Murine astrocytoma and CHO lines. 53
2.2.3. Trypsinisation. 53
2.2.4. Preparation of base-coated flasks. 54
2.2.5. Preparation of spheroids. 54
2.2.6. Autoradiography. 55
2.2.7. Nucleotide transfer. 55
2.3. NSCLC Chemosensitivitv Assays. 57
2.3.1. Clonogenic assay: monolayer. 57
2.3.1.1. 24 hour drug exposure. 57
2.3.1.2. 72 hour drug exposure. 58
2.3.2. MTT assay. 58
2.3.3. Clonogenic assay: spheroid. 59
iv
2.4. Murine Astrocytoma Cell Lines. 60
2.4.1. Clonogenic assay. 60
2.4.2. Genetic marking with B-galactosidase. 61
2.5. CHO Cell Lines. 62
2.5.1. Clonogenic assay. 62
2.5.2. Growth rate. 63
. . .2.5.3. H thymidine incorporation: coculture of 
CHO-K1-BG and Adrr . 63
2.5.3.1. Autoradiography. 64
2.5.3.2. Scintillation counting. 65
2.5.4. Genetic marking of cells with
B-galactosidase. 66
2.5.4.1. DNA transfection. 66
2.5.4.2. Retroviral infection. 67
2.5.4.3. G418 titration. 68
2 .5.4.4. B-galactosidase staining. 68
2.5.5. CHO monolayer coculture. 69
2.5.6. CHO spheroid coculture. 70
2.5.6 .1. Assessment of optimum initial ratio of
CHO-K1-BG and Adrr to produce mixed
spheroids. 70
2.5.6 .2. Confirmation of heterogeneity within
individual spheroids. 71
2.5.6 .3. CHO spheroid coculture. 7 2
2.6. Microiniection of cells. 73
2.6.1. Preparation of microelectrodes. 73
2.6.2. Injection procedure. 73
2.7. Scraoe loading. 74
v
Chapter 3 - STUDY OF THE RELATIONSHIP BETWEEN
INTERCELLULAR COMMUNICATION AND DRUG 
RESISTANCE. 75
3.1. Introduction. 75
3.2. Assessment of cell-cell communication. 77
3.2.1. Transfer of 3H uridine nucleotides. 77
3.2.2. Autoradiography. 7 8
3.2.3. Quantification of gap junctional
communication. 80
3.3. Cytotoxicity assays. 83
3.3.1. Introduction. 8 3
3.3.2. Clonogenic and MTT assays: 24h drug exposure. 84
3.3.3. Clonogenic assay: 72h drug exposure. 85
3.3.4. Spheroid clonogenic assay. 86
3.4. Discussion. 87
3.4.1. Introduction. 87
3.4.2. Cytotoxicity assays. 88
3.4.3. Role of spheroid geometry. 89
3.4.4. Relevance of cytotoxicity assay techniques. 90
3.4.5. Potential role of GSH in determining
cytotoxicity. 93
Chapter 4 - STUDY OF THE INTERACTION OF SENSITIVE AND
RESISTANT CELLS IN MIXED CULTURE. 95
4.1. Introduction. 95
4.2. Studies with sensitive and resistant murine 
astrocytoma cell lines. 96
4.2.1. Introduction. 96
vi
4.2.2. Genetic marking with B-galactosidase. 97
4.2.3. Assessment of chemosensitivity. 97
4.3. Studies with sensitive and resistant Chinese 
hamster ovarv cell lines. 101
4.3.1. Introduction. 101
4.3.2. Confirmation of chemosensitivity. 102
4.3.3. Coculture of sensitive and resistant cells:
preliminary studies of H thymidine 
incorporation. 102
4.3.3.1. Introduction. 102
4.3.3.2. Scintillation counting. 104
4.3.3.3. Autoradiography and labelling index. 104
4.3.3.4. Scintillation counting: effect of cell
density. 105
4.3.4. Genetic marking with B-galactosidase. 109
4.3.4.1. Introduction. 109
4.3.4.2. Retroviral infection. 110
4.3.4.3. G418 titration. Ill
4.3.4.4. DNA transfection. 112
4.3.4.5. Characteristics of CH0-K1-BG
cell line. 113
4.3.5. Coculture studies with marked lines. 114
4.3.5.1. Rationale of technique. 114
4.3.5.2. Monolayer coculture : adriamycin. 116
4.3.5.3. Monolayer coculture : mitozantrone. 118
4.3.5.4. Monolayer coculture : vincristine. 119
4.3.5.5. Spheroid coculture. 120
4.3.5.5.1. Introduction. 120
4.3.5.5.2. Initiation ratio of mixed 
spheroids. 122
4.3.5.5.3. Conf irmation of heterogeneity 
within mixed spheroids. 123
vii
4.3.5.5.4. Mixed spheroid clonogenic assay:
adriamycin. 124
4.3.6. Gap junctional communication between
CHO cells. 124
4.3.6.1. Introduction. 124
4.3.6 .2. Microinjection. 125
4.3.6.3. Nucleotide transfer. 126
4.4. Passage of adriamvcin through gap junctions. 127
4.4.1. Introduction. 127
4.4.2. Microinj ection. 128
4.4.3. Scrape loading. 130
4.5. Discussion. 132
4.5.1. Introduction. 132
4.5.2. Alternative explanations for absence of
interaction. 133
4.5.2.1. Inhomogeneity of cell distribution. 133
4.5.2.2. Duration of cell-cell contact. 134
4.5.2.3. Adequacy of communication. 136
4.5.2.4. Drug passage between cells. 137
4.5.2.5. Multiplicity of resistance mechanisms. 139
REFERENCES 142
viii
ACKNOWLEDGEMENTS
I should like to thank the following for their help:
The Cancer Research Campaign for financial support.
Dr John Pitts for his valued advice, guidance and 
patience.
Prof Stan Kaye and Dr Ian Freshney for helpful 
discussions.
Ms Diana Morgan for introducing me to the rudiments of 
tissue culture.
Dr Jane Plumb for help with the MTT assays.
Dr Ephraim Kam for assistance with microinjections.
And Heather for late night typing.... and everything else.
INDEX OF FIGURES
following
page
1.
2.
3.
4.
5.
6.
7.
8 .
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
Intercellular communication in NSCLC lines: 
transfer of 3H uridine nucleotides between 
donor and recipient cells.
Intercellular communication in NSCLC lines: 
grain counts over recipient cells.
NSCLC chemosensitivity: clonogenic assay.
NSCLC chemosensitivity: MTT assay.
NSCLC chemosensitivity: comparison of 24 
and 72 hour drug exposure.
NSCLC chemosensitivity: spheroid clonogenic 
assay.
Chemosensitivity of murine astrocytoma lines: 
clonogenic assay.
Effect of reduction in cell density on 
chemosensitivity of murine astrocytoma 
lines: clonogenic assay.
CHO chemosensitivity: clonogenic assay.
Coculture of CHO-K1 and Adrr : 3H thymidine 
incorporation assay.
Coculture of CHO-K1 and Adrr: 3H thymidine 
incorporation assay. Day 3 labelling.
Coculture of CH0-K1 and Adrr: 3H thymidine 
incorporation assay. Day 2 labelling.
CHO chemosensitivity: comparison of CH0-K1 
and CH0-K1-BG.
Growth curves of CHO lines.
6-galactosidase as a lineage marker in 
coculture studies.
Coculture of CH0-K1-BG and Adrr : monolayer 
clonogenic assay, adriamycin.
Coculture of CHO-K1-BG and Adrr : cell counts 
after 24 hour drug exposure.
Coculture of CHO-K1-BG and Adrr : monolayer 
clonogenic assay, mitozantrone.
78
80
84
84
86
87
98
100
102
104
106
107
113
113
115
116
117
118
x
19. Coculture of CH0-K1-BG and ADR-6 : monolayer 
clonogenic assay, vincristine. 119
xi
INDEX OF TABLES following
page
1. Characteristics of NSCLC cell lines. 50
• • • T •2. NSCLC chemosensitivity: H leucine
incorporation assay. 77
3. Intercellular communication in A549: effect
of different indices of coupling. 80
4. Intercellular communication in NSCLC
cell line. 81
5. NSCLC chemosensitivity: comparison of 
clonogenic and MTT assays. 84
6 . Chemosensitivity of murine astrocytoma lines:
35S methionine uptake assay. 96
7. Effect of G418 concentration on survival of 
CHO-K1 and Adrr . Ill
8 . Effect of initiation ratio of CH0-K1-BG:Adrr
on composition of mixed spheroids. 122
9. Confirmation of heterogeneity within 
individual spheroids. 123
10. Coculture of CHO-K1-BG and Adrr : spheroid 
clonogenic assay, adriamycin. 124
xii
ABBREVIATIONS.
ATP adenosine triphosphate
BCF base coated flask
BCNU 1,3-bis(2-chloroethyl)-1-nitrosourea
BDH British Drug Houses
BSO buthionine sulfoxamine
BSS buffered salt solution
B-gal B-galactosidase
CAMP cyclic adenosine monophosphate
CDNA copy deoxyribonucleic acid
CEA carcinoembryonic antigen
CR contact resistance
DMSO dimethyl sulfoxide
DNA deoxyribonucleic acid
ELISA enzyme linked immunoassay
GSH glutathione
GST glutathione-S-transferase
HGPRT hypoxanthine-guanine phosphoribosyltransferase
LI labelling index
LT lymphotoxin
mAMSA 4 - (9-acridinylamino) methanesulfon-m-anisidide
MDR multidrug resistance
mRNA messenger ribonucleic acid
MTT 3-(4,5-dimethylthiazol-2-yl)-2,5 
diphenyltetrazolium bromide
NSCLC non-small cell lung cancer
PBS phosphate buffered saline
RNA ribonucleic acid
SCE sister chromatid exchange
SCLC small cell lung cancer
SD standard deviation
SEM standard error of the mean
T-B touching minus background
T/B touching divided by background
TCA trichloroacetic acid
TNF tumour necrosis factor
TPA 12-o-tetradecanoyl phorbol-13-acetate
topo II topoisomerase II
UV ultraviolet
X-gal 4-chloro-5-bromo-3-indoyl-B-galactosidase
xiii
SUMMARY
The gap junction is an array of channels spanning the two 
membranes of adjacent cells and linking their cytoplasms. 
The aim of this thesis was to examine the role which 
intercellular communication through gap junctions might 
play in the development of cytotoxic drug resistance.
Increased junctional communication has been associated 
with resistance to radiation and to cytotoxic 
lymphokines. The explanation for this phenomenon is not 
clear, although it is possible that sharing of metabolic 
pools between coupled cells may allow them to withstand 
damage more effectively than isolated cells. To
investigate whether this relationship between 
communication and resistance is a generalised one, 
applicable to conventional cytotoxic drugs, the strength 
of coupling of a panel of seven human NSCLC cell lines 
was measured and compared with the chemosensitivity of 
these lines to adriamycin.
Communication was assessed by autoradiographic detection 
of transfer of 3H uridine nucleotides between cells. The 
strength of coupling varied widely between the cell lines 
and they could be separated into three groups: those
which exhibit strong coupling, L-DAN and A549; those 
which exhibit weak coupling, SK-MES-1, Calu-3 and NCI- 
H125; and an intermediate group, WIL and NCI-H23. 
Adriamycin chemosensitivity of each cell line was
xiv
assessed in monolayer by both clonogenic and MTT assays. 
The range of IC50 values as measured by either assay was 
extremely narrow with no important differences between 
the cell lines. Thus, despite the wide spectrum of 
junctional communication observed in these lines, this 
did not correlate with their adriamycin resistance. 
Chemosensitivity of three dimensional spheroids of L-DAN 
and SK-MES-1 was also assessed by clonogenic assay but 
again this was not related to their communication.
Interaction between drug sensitive and resistant cell 
lines has been demonstrated in mixed culture. 
Nitrosourea resistance is transferred between cells in 
spheroids and ouabain resistance is transferred in 
monolayer culture by the rapid diffusion of K+ and Na+ 
ions through gap junctions. The membrane pumps in the 
ouabain resistant cells maintain physiological ion 
concentrations in the cytoplasms of both cell types. It 
seems possible, therefore, that other forms of drug 
resistance which are dependent on the cytoplasmic 
concentration of small ions or molecules should be 
transferred between cells joined by gap junctions.
The MDR phenotype has been related to the presence of a 
membrane pump, P-glycoprotein, which reduces 
intracellular drug concentration. The behaviour of 
normal (CH0-K1), resistant (Adrr) and hypersensitive 
(ADR-6) Chinese hamster cell lines which have been shown 
to exhibit junctional communication was examined in mixed
xv
culture. The CH0-K1 cells were genetically marked by 
transfection with a bacterial B-galactosidase gene. Its 
enzyme produces a blue product with appropiate substrate 
and allows identification of the individual response of 
two cell types in mixed culture. Clonogenic assays were 
performed after exposure of mixed monolayer or spheroid 
culture to either adriamycin, mitozantrone or 
vincristine. In individual assays Adrr is xlOO more 
resistant to adriamycin and x20 more resistant to 
mitozantrone than CH0-K1, whereas ADR-6 is x2 more 
sensitive to vincristine. However, in mixed culture, the 
chemosensitivities of the cell lines were unchanged with 
no evidence of resistance transfer in this system.
xvi
CHAPTER 1 INTRODUCTION
1.1. Heterogeneity of cellular and tissue function
1.1.1. Heterogeneity of normal cellular function
Heterogeneity of cellular and thus of tissue function is 
the basis on which the activities of all complex 
multicellular organisms depend. Although each cell may 
have an identical genetic complement, the expression of a 
selected proportion of this allows the cell to produce a 
specific differentiated phenotype, appropriate to the 
function of that cell in the organism as a whole. Thus 
some cells produce contractile elements and function as 
muscle cells to endow the organism with motility; some 
develop suitable polar orientation and specialised 
membrane modifications to form epithelial tissues lining 
body surfaces; in others the manufacture of a specific 
product is dominant as in osteocytes which produce and 
secrete large amounts of extracellular matrix on which 
minerals are later deposited to provide structural 
rigidity to the skeleton.
1.1.2. Cell-cell communication
To coordinate the activity of the organism as a whole, 
however, it is necessary that some form of dialogue or 
cooperation is established between this large family of 
cells. Several mechanisms have evolved through which
1
such communication may occur in order that each cell does 
not behave in an independent manner and by which each 
cell is able to influence the activity of another.
These mechanisms can act between cells situated some 
distance apart through the production of circulating 
messengers or hormones as in the endocrine and paracrine 
systems. When cells are in close proximity mechanical 
factors become important and cell crowding and
t
orientation may play a role in behaviour. One additional 
means of communication afforded by close contact is that 
of direct passage of molecules from the cytoplasm of one 
cell to that of its neighbours through transmembrane 
channels known as gap junctions. This last mechanism 
will be discussed in more detail in a section 1 .2 ..
1.1.3. Tumour cell heterogeneity
Despite their presumed monoclonal origin from a single 
transformed cell, tumour cells have also been shown both 
in vivo and in vitro to exhibit considerable 
heterogeneity in a large number of phenotypic variables 
including morphology, growth rate, expression of specific 
markers, metastatic propensity and sensitivity to 
radiation and to cytotoxic drugs (Heppner and Miller, 
1989). A number of explanations for this heterogeneity 
have been proposed including the underlying genetic 
instability associated with neoplasia (Nowell, 1976) and
2
the selective pressure of the cell's microenviroment 
within the tumour (Sutherland, 1988).
1.1.4. Interaction of tumour subpopulations
As in the organism as a whole, there is extensive 
evidence that these cellular subpopulations do not behave 
in an independent manner, but that the presence of one 
subpopulation can have considerable influence on the 
activities of another (Heppner, Miller and Miller, 1983).
Itaya et al. (1989) have recently demonstrated in murine
colorectal carcinoma cells that, in contrast with the 
parent line, isolated clones of the cell line are often 
phenotypically unstable. They attributed the phenotypic 
stability of the parent line to interactions between the 
constituent subpopulations, and suggested that such 
interaction is necessary in order to allow the tumour 
cell population to retain its heterogeneity and allow 
numerous subpopulations to exist. The ability to isolate 
clones with markedly different growth rates from advanced 
tumours suggests that some interaction must be occuring 
otherwise the most rapidly growing and aggressive 
populations would soon come to dominate the tumour 
(Heppner, 1989).
It has been demonstrated by the use of mixtures with 
differing characteristics that the growth rate of one 
population can be altered by the presence of a second
3
population with a different growth rate (Miller et al., 
1988; Tofilon, Buckley and Deen, 1984). Using a mouse 
mammary tumour model Miller et al. (1988) showed both in 
vivo and in vitro that in some cases one subpopulation is 
able to suppress the growth of another, and obtained 
evidence of a growth-inhibiting factor produced by the 
dominating cell line. Several groups have also shown 
that the interaction of mixed drug sensitive and
resistant populations can lead to an alteration in drug 
response (Miller, Miller and Heppner, 1981; Tofilon, 
Buckley and Deen, 1984; Bradford et al. . 1986; Tofilon,
Arundel and Deen, 1987) (See section 1.7.). The
mechanisms of the majority of these interactions remain 
obscure. In some cases interaction is dependent on host 
responses such as altered immune reaction and drug 
metabolism, although in other cases the interaction 
appears to occur directly between the tumour cells
themselves (Heppner, 1989). The importance of the gap
junction in intercellular communication and its possible 
role in mediating such interactions will now be 
discussed.
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1.2. The gap junction
1.2.1. Metabolic cooperation
The description of metabolic cooperation by Subak-Sharpe, 
Burk and Pitts in 1966 was the first indication of the 
potential implications of cell-cell communication for 
altering tissue phenotype. They showed that mutant 
Syrian hamster fibroblasts lacking the hypoxanthine- 
guanine phosphoribosyltransferase (HGPRT) enzyme, which 
were unable to incorporate hypoxanthine into nucleic acid 
when cultured alone, did so when grown in contact with 
wild-type cells. Cell-cell transfer of the enzyme or its 
messenger RNA (mRNA) were considered possible 
explanations of this phenomenon and Kolodny (1971) 
suggested that such transfer did occur. Subsequent work 
by Pitts and Simms (1977) showed that intercellular 
transfer of such macromolecules was not possible and that 
this metabolic cooperation was mediated by exchange of 
nucleotides between the mutant and wild-type cells, 
allowing the mutant cells to bypass the metabolic block 
caused by their lack of enzyme.
1.2.2. Gap junction structure
Further studies have shown that the route through which 
the nucleotides travelled from cell to cell was the gap 
junction (Gilula, Reeves and Steinbach, 1972). This is a 
channel spanning the two membranes of adjacent cells and
5
linking their cytoplasms. X-ray diffraction studies have 
shown the channel to be composed of six protein subunits 
radially arranged within the membrane and surrounding an 
aqueous central pore of approximately 2nm diameter 
(Makowski et al.. 1977).
Gap junctions occur as close-packed arrays of channels 
which form in regions where the membranes of two cells 
come into close contact. At their extracellular face the 
junctional units protrude l-2nm into the extracellular 
space with the result that a characteristic 2-4nm gap 
remains between opposing membranes and gives this 
structure its name. This is in contrast to the 
appearances of tight junctions which occlude the spaces 
between cells in epithelial sheets. In these regions the 
membranes are closely opposed and the intercellular cleft 
obliterated.
X-ray diffraction studies have shown that the channel 
protein subunits are arranged at a slight angle to each 
other and there is some evidence that a twisting movement 
in these subunits may result in closure of the central 
pore at its cytoplasmic end, thus acting as a mechanism 
for gating the junctional channel (Unwin and Ennis, 
1984) .
There has been some controversy over the identification 
of the proteins involved in forming gap junctions. 
However there is now evidence to suggest that a highly
6
conserved, tissue invariant 16 kilodalton (kD) protein is 
the core component of the junctional channel (Finbow et 
al., 1983; Buultjens et al. . 1988), whilst one of a
family of tissue specific proteins (the connexins) is 
also required for functional coupling. It is probable 
that specificity in formation of junctions between cells 
as reported in vitro by Pitts and Burk (1976) is 
dependent on the connexins. They observed that rat liver 
epithelial (BRL) cells showed extensive communication in 
pure culture and that C13 hamster fibroblasts also formed 
junctions among themselves, but in mixed culture there 
was little heterologous coupling between the two cell 
types.
This specificity of interaction, and the associated 
sorting-out of cell types during tissue differentiation, 
forms the basis for communication compartments in vivo. 
where a boundary effect results from the reduced 
frequency of heterologous relative to homologous junction 
formation (Pitts, Finbow and Kam, 1988).
1.2.3. Junctional permeability
With the use of a number of different fluorescent probes 
of defined size the permeability properties of junctional 
channels have been elucidated. For arthropod junctions 
the exclusion limit is 1500 daltons (Simpson, Rose and 
Loewenstein, 1977) whilst for mammalian junctions the 
limit is 900 daltons (Flagg-Newton, Simpson and
7
Loewenstein, 1979), which is broadly in keeping with 
estimates based on the diameter of the aqueous channel 
derived by X-ray diffraction.
In effect the junction acts as a sieve retaining 
macromolecules within the cell but allowing small 
molecules to pass freely without further selection. In 
practice there are few molecules of a size near to the 
critical limit whose ability to traverse the junction 
would be in doubt. Most cytoplasmic constituents are 
either much too large to pass, e.g. nucleic acids and 
proteins, or are relatively small, e.g. ions and 
nucleotides, and pass freely. The rate of movement 
through the junctions is very rapid. Pitts et al. (1985) 
have calculated that in metabolic cooperation studies 
with BHK cells more than 106 nucleotides must pass 
between each cell pair per second and it is likely that 
other small molecular weight components will be 
traversing the junctional channels at similar rates along 
diffusion gradients. The potential for dialogue between 
coupled cells is therefore immense.
It is generally believed that in the normal, resting 
state the junctional channel is open allowing maximal 
communication (Pitts and Finbow, 1986) but a number of 
modulators of communication have been identified. High 
intracellular free ionised calcium concentration (Rose 
and Loewenstein, 1975) and low pH (Turin and Warner, 
1977) have been shown to uncouple cells. Extracellular
8
uncouplers include the tumour promotor 12-O-tetradecanoyl 
phorbol-13-acetate (TPA) (Yotti, Chang and Trosko, 1979), 
octanol (Johnston, Symon and Ramon, 1980), retinoic acid 
(Pitts et_al., 1986) and procaine (Dertinger and Hulser, 
1984). It has also been reported that cyclic adenosine 
monophosphate (cAMP) can promote junctional communication 
in poorly coupled cells (Azarnia, Dahl and Loewenstein, 
1981). In addition, it has been demonstrated using a 
mouse skin model that TPA can increase the otherwise poor 
transboundary junctional communication between dermis and 
epidermis (Kam and Pitts, 1988).
1.2.4. Detection and function of gap junctions
Gap junctions are ubiquitous structures found in tissues 
of all metazoan animals. They are formed in virtually 
every cell type with the few exceptions where they are 
lost during the terminal stages of differentiation. 
Their appearance and disposition can be demonstrated by 
thin-section and freeze-fracture electron microscopy 
(Revel and Karnovsky, 1967). In addition to the 
previously described metabolic cooperation studies, their 
functional activity can be detected by measurement of 
electrical coupling (Loewenstein, 1979), by intercellular 
passage of dye following microinjection (Loewenstein and 
Kanno, 1964) or entry via a transient tear in the cell 
membrane (scrape-loading) (El-Fouly, Trosko and Chang, 
1987) and by autoradiographic detection of 3H labelled 
nucleotide transfer (Pitts and Simms, 1977).
9
The role of gap junctions in normal tissue function is 
widely debated. They are considered to be involved in 
the control of cellular growth and differentiation. The 
presence of coupling between cells in a tissue produces a 
partial syncitial state where all cells in the group are 
able to freely transfer their small ions and metabolites 
and thus integrate their metabolic behaviour. In 
addition to the reduced coupling at boundaries between 
heterologous cells in vitro (Pitts and Burk, 1976; Pitts 
and Kam, 1985) , communication compartments have also been 
defined in a number of tissues in vivo (Kam, Melville and 
Pitts, 1986) and it has been proposed that gap junctions 
may regulate growth within the compartment by means of 
small diffusable molecules such as growth factor-induced 
second messengers whose concentration within the 
compartment would depend on the compartment size as 
defined by communication boundaries (Pitts and Finbow, 
1986).
Examples of coupling of capillary endothelial cells to 
surrounding stromal cells have also been reported (Kam, 
Mellville and Pitts, 1986) suggesting that junctional 
communication may also play a role in the delivery of 
nutrients and metabolites into tissues.
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1.2.5. The role of gap junctions in malignancy
The importance of gap junctions in the processes of 
growth and differentiation of normal tissues and the 
disruption of these controls associated with neoplastic 
transformation has led to extensive investigation of the 
relationship between intercellular communication and 
malignancy.
In the multistage model of carcinogenesis, several 
sequential events are involved in the malignant 
transformation of a cell. The first or initiating event 
must be followed by one or more promoting events before 
the cell is fully transformed. The observation that one 
of the most effective tumour promotors, the phorbol ester 
TPA, uncoupled cells in some situations led to the 
suggestion that loss of junctional communication between 
initiated and normal cells may play a part in allowing 
the initiated cell to escape from normal growth 
regulation (Yotti, Chang and Trosko, 1979).
A role for the gap junction in the malignant process was 
strengthened further by the report that a reduction in 
communication can also occur as a result of oncogene 
expression (Atkinson et al., 1981), whilst McNutt,
Hershberg and Weinstein (1971) reported that the number 
of gap junctions was inversely correlated with the degree 
of dysplasia in cervical epithelium and that junctions 
were rare in frank invasive carcinoma. Conversely,
11
Brauner and Hulser (1987) presented a preliminary report 
using an in vitro model of tumour cell invasion 
indicating that the presence of junctions is positively 
correlated with invasive behaviour.
In 1971 a number of tumour cell lines with poor 
junctional communication were identified and it was 
suggested that loss of junctions was a precondition for 
malignancy (Azarnia and Loewenstein, 1971). Since then, 
however, a large number of communication competent tumour 
cell lines have been identified (Miller et al. . 1983;
Morgan et al., 1982). Thus the interrelationship between 
junctional communication and malignancy is clearly a 
complex one and much remains to be elucidated.
1.3. Tumour spheroids and contact resistance
1.3.1. Spheroids and radioresistance
The suggestion that gap junctional communication may play 
a role in the response of tumours to therapeutic 
intervention was prompted by study of the contact effect 
or contact resistance (CR). This phenomenon was first 
reported by Durand and Sutherland (1972) who found that 
tumour cells when cultured as three-dimensional 
multicellular spheroids were more resistant to the 
cytotoxic effects of ionising radiation than when the 
same cells were cultured as monolayer. Cells grown as 
spheroids but separated into a single cell suspension by
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trypsinisation immediately before irradiation showed an 
intermediate survival, and this enhanced survival reduced 
with increasing time interval between trypsinisation and 
irradiation and had returned to the control level by 10 
hours.
Thus, although three-dimensional contact appears 
important for the development of CR, direct cell-cell 
contact at the time of irradiation is not crucial for 
this effect. The cause of this difference was attributed 
to the altered environmental influences acting on the 
cells in view of the three-dimensional geometry within 
the spheroid and therefore related to the intimate 
intercellular contact afforded by this arrangement.
This spheroid model has since been widely adopted in an 
attempt to simulate in vitro the characteristics of the 
three-dimensional growth of tumours in vivo. The closest 
analogy is between spheroids and unvascularised 
micrometastases, although there are also similarities 
with poorly vascularised regions of larger solid tumours 
(Sutherland, 1986). The limitations of this model 
include the absence of tumour stroma or circulation, and 
of the influences of the host's metabolic processes.
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1.3.2. The influence of spheroid microenvironment on 
response
Oxygen, glucose and other nutrients, hormones and growth 
factors reach the cells within the spheroid by diffusion 
from the surrounding medium resulting in the 
establishment of diffusion gradients between the outer 
and inner spheroid regions for these essential factors. 
Conversely a gradient for H+ , lactate and other 
metabolic products develops in the opposite direction 
(Sutherland, 1986) . As a result, in the centre of larger 
spheroids necrotic regions develop, analogous to the 
appearances commonly seen in vivo when rapidly growing 
tumours outstrip their blood supply.
It has been proposed that the reduced radiosensitivity of 
spheroids could in part be attributed to the presence of 
viable, hypoxic and therefore radioresistant cells within 
the inner spheroid regions (Sutherland and Durand, 1984). 
There is a well established relationship between cellular 
hypoxia and radioresistance which is apparent when PC>2 < 
lOmmHg. Such levels have frequently been observed in 
human and rodent tumours and resistant hypoxic cells have 
been demonstrated in spheroids (Sutherland, 1986). 
Dertinger and Hulser (1981) however demonstrated that 
contact resistance can be detected in we11-oxygenated 
outer spheroid cells and that the magnitude of CR is 
uniform regardless of the position of the cell within the 
spheroid.
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Another major factor which may contribute to CR is 
reduced growth rate and altered cell cycle phase 
distribution of inner spheroid cells (Sutherland and
Durand, 1984). Assessment of cell cycle phase
distribution by flow cytometry has shown that the
distribution of outer cells is similar to exponentially- 
growing monolayers whereas up to 90% of cells in the 
inner regions have a G1 phase DNA content (Freyer and 
Sutherland, 1980). However Hinz and Dertinger (1983)
found that such kinetic influences were unable to explain 
CR. They reported that the radioresistance of outer 
proliferating cells was comparable to inner non­
proliferating cells. Moreover in the original study of 
Durand and Sutherland (1972), very young spheroids
composed of only 7-15 cells were used which therefore
remained in exponential growth with a doubling time
identical to that of single cells. Although Hinz and 
Dertinger found the decay of CR (when spheroid cells were 
irradiated at various time intervals after 
trypsinisation) to be comparable to that reported by 
Durand and Sutherland, their findings differed in that 
they also observed that CR occurred only in spheroids of 
more than 2mm diameter and that the radiosensitivity of 
very small spheroids was comparable to that of
monolayers.
In summary, therefore, although there is some evidence
that hypoxia and altered cell cycle phase distribution in 
the inner spheroid region may contribute to the
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phenomenon of CR, they do not provide an adequate 
explanation in all cases, and it appears that some 
additional protection is afforded by the three-
dimensional contact in this system.
1.3.3. Intercellular communication and contact resistance
Further light was thrown on this phenomenon by the 
observation of Dertinger and Hulser (1981) that CR was a 
property only of cell lines which displayed gap 
junctional communication and that the magnitude of CR was 
related to the extent of communication as measured
electrophysiologically. They reported that there was no
difference in radiosensitivity between monolayers or 
spheroids of uncoupled cell lines, and that blockage of 
communication by TPA could reverse the CR in spheroids of 
well-coupled lines.
It seemed possible, therefore, that the increased 
opportunity for intercellular communication when cells 
were in three-dimensional contact might explain CR if 
exchange of small signal molecules occurred between cells 
in coupled spheroids.
It has been suggested, however, that rather than the 
expected increase in opportunities for intercellular 
communication, cells within spheroids may, in fact, be
less well coupled than when cultured as monolayer. 
Dertinger, Hinz and Jakobs (1982) reported a reduction in
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coupling in the outer cells of spheroids with increasing 
age and this finding was confirmed independently by 
Sutherland (1986) who showed reduced spread of Lucifer 
Yellow in older spheroids produced from several different 
cell lines.
Other aspects of the CR phenomenon are inconsistent with 
an explanation based on metabolic cooperation. The 
increased survival of disaggregated spheroid cells is 
difficult to explain by intercellular transfer of any 
signal molecule, and such transfer would also be expected 
to occur to a significant extent in monolayer culture as 
indicated by the examples of metabolic cooperation.
There is some evidence however in support of a role for 
the tripeptide glutathione (GSH) in the development of 
CR. Cellular damage by indirectly ionising radiation, 
including the gamma irradiation in the above studies, is 
the consequence of the production of highly chemically 
reactive radical species and as GSH can act as an 
intracellular free radical scavenger and radioprotector 
(Biaglow et al., 1983; Edgren and Revesz, 1985), it may 
limit radiation induced damage.
The effect of GSH on radiation response has been studied 
by Edgren (1982) who reported that coculturing of cells 
deficient of GSH with normal cells increases the DNA 
repair capacity of the deficient cells, whereas the 
addition of medium conditioned by the normal cells had no
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effect. Although junctional communication was not 
assessed in these cells, it seems possible that this 
interaction was the result of metabolic cooperation 
mediated by GSH transfer from the normal to the deficient 
cells. Kavanagh et al. (1988) have confirmed that GSH 
can be transferred from cell to cell through gap 
junctions.
In contrast, Dertinger and Hulser (1984) have attributed 
CR to differentiation occurring in spheroids. It has 
been shown that spheroids of human colonic adenocarcinoma 
will form pseudo-glandular structures which resemble the 
appearances of tumours in vivo and also express increased 
amounts of the tumour associated protein carcinoembryonic 
antigen (CEA) compared to monolayers (Sutherland, 1986), 
both of these features suggesting a degree of 
differentiation in spheroids above that encountered in 
monolayers.
1.3.4. In vivo models of contact resistance
Subsequent studies have shown that CR operates in vivo in 
rodent tumours (Hill, Warren and Bush, 1979) and in human 
tumour xenografts (Guichard, Dertinger and Malaise,
1983) , suggesting that this phenomenon may make a 
significant contribution to the radiation response of 
human tumours. The previous correlation between CR and 
junctional communication was also manifest in this model. 
Dertinger, Guichard and Malaise (1984) studied this
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relationship in four xenografts and reported that in 
three of the tumours which exhibited CR, junctional 
communication could be demonstrated (communication in 
these lines was assessed by electrical coupling in 
vitro) . The other tumour which did not show CR also 
failed to show coupling.
By comparing the tumour radiosensitivity in mice 
asphyxiated in a nitrogen atmosphere for 10 minutes 
before irradiation with that in live air breathing mice, 
Guichard et al. (1983) have demonstrated that in this
model system, as in spheroids, hypoxia was not an 
adequate explanation for the degree of CR observed.
1.3.5. Spheroid resistance to cytotoxic drugs
In parallel to the above series of experiments comparing 
radiosensitivity of spheroid to monolayer culture, the 
role of the three dimensional spheroid geometry in 
chemosensitivity has also been widely studied. Although 
there are some exceptions (Tofilon, Arundel and Deen, 
1987), most studies show a survival advantage afforded to 
cells when cultured as spheroids for a number of 
cytotoxic drugs. In addition to the factors modifying 
radiation response of spheroids, the study of spheroid 
chemosensitivity is further complicated by alterations in 
drug accessibility, uptake and metabolism. Penetration 
barriers have been suggested to be at least partly 
responsible for spheroid resistance to vinblastine
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(Nederman, Carlsson and Malmqvist, 1981; Nederman, 1984), 
adriamycin (Durand, 1976; Sutherland et al. . 1979; Kerr
et al. . 1986) and 4'-(9-acridinylamino) methanesulfon-m-
anisidide (mAMSA) (Wilson, Whitmore and Hill, 1981).
Increased spheroid drug resistance was first demonstrated 
to adriamycin. Durand (1976) has shown that even small 
spheroids of the Chinese hamster fibroblast line V79, 
composed of 5-15 cells, which would not be expected to 
present any penetration barrier, were more resistant to 
adriamycin than single cells. Subsequent studies with 
larger spheroids (Durand, 1981) confirmed the presence of 
a diffusion gradient of adriamycin into the spheroids, 
but showed that for a given intercellular adriamycin 
concentration spheroid cells had increased survival 
relative to monolayer cells, whilst cells from 
disaggregated spheroids had an intermediate survival.
Similarly, by selective trypsinisation of inner and outer 
cell layers, Sutherland and co-workers (1979) showed that 
cells in inner regions of EMT-6 mammary tumour spheroids 
were more resistant to adriamycin but that this 
difference could only partly be accounted for by a 
penetration barrier. They suggested that the increased 
resistance of the inner cells could result from other 
factors related to the three dimensional microenviroment 
of the cells, or alterations in the metabolism of the 
cells or of the drug itself.
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Wibe (1980) subsequently extended these studies to the 
examination of the chemosensitivity of a human cervical 
carcinoma line to vincristine. A marked increase was 
seen in the resistance of spheroids compared to 
exponentially growing monolayers, although plateau-phase 
monolayers were even more resistant than spheroids. This 
result could be attributable to kinetic factors, as the 
spindle poison vincristine is inactive against non­
cycling cells. However, in contrast to the earlier 
results with adriamycin, the sensitivity to vincristine 
was independent of distance from the spheroid surface, a 
surprising finding in view of the presumed reduction in 
cell cycling with increased spheroid depth.
By treating cells from spheroids with mAMSA at varying 
times following trypsinisation, Wilson, Whitmore and Hill 
(1981) showed a gradual loss of spheroid resistance to 
the drug with time, to reach a level comparable to that 
of exponentially growing monolayers after 28 hours, thus 
paralleling the decay of radiation CR. On this occasion 
the inner cells were more resistant than the outer layers 
although even the latter demonstrated improved survival 
over exponential cells.
Thus, there is a body of evidence which indicates that, 
as with radiation response, the three dimensional 
spheroid structure appears to provide some additional 
chemoresistance to cells beyond that which can be 
attributed to kinetic and penetration influences. Unlike
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radioresistance, however, the contribution of gap 
junctional communication to this phenomenon has not yet 
been assessed.
1.4. Intercellular communication and lymphokine response
It has more recently been reported that the role of gap 
junctional communication in cellular resistance is not 
wholly dependent on the three dimensional structure of 
spheroids and xenografts nor limited to their response to 
radiation.
In monolayer culture Fletcher et al. (1987) demonstrated 
that communication-competent Chinese hamster ovary (CHO) 
cells were resistant to the cytolytic action of the 
lymphokines, tumour necrosis factor (TNF) and lymphotoxin 
(LT) . Exposure of the cells to TPA or culturing at low 
density, both of which would be expected to reduce the 
frequency of intercellular communication, increased their 
sensitivity to the lymphokines. In contrast, two 
subclones of mouse L cells which do not communicate 
through junctions and which were TNF/LT-sensitive became 
less sensitive after promotion of coupling by elevation 
of their intracellular cAMP. In addition they studied 
the LA25 transformant of the NRK cell line which is 
infected with a temperature sensitive mutant of the Rous 
sarcoma virus and exhibits coupling and TNF/LT resistance 
at the restrictive temperature (39°C) where the oncogene 
is not transcribed. Reduction to the permissive
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temperature of 33°C causes rapid uncoupling and the cells 
then became sensitive to the lymphokines. They suggested 
that modulation of the cellular response to these agents 
might be explained by the passage of small signal 
molecules from cell to cell in a coupled population.
There is conflicting evidence regarding the relationship 
between the resistance of cells to TNF and to members of 
the MDR group of drugs. Several studies (Dollbaum et 
al.. 1988; Hofsli and Nissen-Meyer, 1989; Fruehauf,
Mimnaugh and Sinha, 1991) have suggested cross-resistance 
between TNF and MDR drugs, but this finding is not 
universal (Matthews and Neale, 1989).
1.5. Mechanisms of cytotoxic drug resistance
1.5.1. Inherent and acquired resistance
In the clinical context the resistance of tumour cells to 
cytotoxic drugs is a major obstacle to effective 
treatment and eradication of the tumour. Cytotoxic drug 
resistance has conventionally been considered to occur in 
two separate settings. The first is that of inherent 
resistance, where from the outset of treatment the tumour 
is unresponsive to available cytotoxic drugs. The second 
form, acquired resistance, describes the situation where 
after an initial tumour response to a drug with shrinkage 
or even apparent disappearance of the tumour, the tumour
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eventually regrows and fails to respond further to the 
drug.
Although this division is not absolute, both varieties of 
resistance are readily identifiable and distressingly 
common in the clinic. Tumours such as colorectal 
carcinoma, renal carcinoma and melanoma belong to the 
inherently resistant group whilst breast and small cell 
lung cancer display acquired resistance in the majority 
of patients.
The explanation for drug resistance can in general be 
considered to arise either from pharmacokinetic factors, 
where the achievement of an adequate intratumoural drug 
concentration is the problem, or from biochemical factors 
where the tumour cells possess or develop a mechanism 
which enables them to withstand attack by the cytotoxic 
drugs. It is not yet clear whether inherent and acquired 
resistance arise through different mechanisms.
A number of such biochemical mechanisms have been 
identified in resistant cells including reduced 
activation of prodrugs, increased drug inactivation and 
over production of target enzymes. One further
resistance mechanism, whereby cells are able to reduce 
the amount of intracellular drug accumulation and 
presumably its delivery to its site of action, has been 
shown to play a major role in the resistance to a number
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of cytotoxic drugs and will be considered in the 
following section.
1.5.2. The multidrug resistant phenotype
Although reduced intracellular drug uptake has been
identified as contributing to methotroxate resistance by 
changes in a drug specific transport mechanism (Hill et 
al.. 1979), and also to resistance to cisplatin (Bungo et 
al.. 1990) and melphalan (Redwood and Colvin, 1980), the
major interest in this field involves a common mechanism 
through which cells develop resistance to a group of 
structurally and functionally unrelated drugs.
This phenomenon was first described by Biedler and Rheim 
in 1970 who found that Chinese hamster lung cells and
P388 leukemia cells which had been made resistant to 
actinomycin D by exposure to increasing concentrations of 
the drug displayed cross resistance to vinblastine and 
daunomycin. The degree of this cross resistance was 
proportional to that of actinomycin D itself. They 
reported that the resistant cells showed reduced 
accumulation of 3H actinomycin D and proposed that this
was the result of reduced membrane permeability to the
drug.
This behaviour was termed pleiotropic or multidrug 
resistance (MDR) and similar findings have been obtained 
by other groups in a range of cell lines. The list of
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drugs within the MDR group has been extended to include 
other anthracyclines and vinca alkaloids as well as 
mitomycin C and the epipodophyllotoxins (Kaye, 1988), 
although the precise pattern of cross resistance varies 
between the different reported lines.
1.5.3. P-glycoprotein
Ling and colleagues, using MDR Chinese hamster lung (V79) 
cells initially selected for resistance to colchicine, 
confirmed that MDR was associated with reduced 
intracellular drug accumulation and subsequently 
identified a plasma membrane associated 170kD 
glycoprotein in these cells which was not present in the 
parental sensitive line (Ling and Thomson, 1973; Juliano 
and Ling, 1976; Bech-Hanson, Till and Ling, 1976). The 
relative amount of this glycoprotein correlated with the 
degree of resistance and reduction in drug accumulation 
in independent clones with stepwise increases in 
resistance. They proposed that this glycoprotein reduced 
intracellular drug accumulation by modifying membrane 
fluidity and reduced the permeation rate of drugs 
entering the cell and suggested that it be called P- 
glycoprotein.
This group subsequently showed that P-glycoprotein was 
also present in MDR mouse and human cell lines and that 
it appeared to be highly conserved (Kartner, Riordan and 
Ling, 1983; Kartner et al. . 1985). They were also able
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to detect P-glycoprotein in much smaller amounts in the 
parent drug sensitive lines and suggested that the 
increased levels found in the resistant lines might arise 
from amplification of a gene present in the parent cells.
1.5.4. P-glycoprotein as an efflux pump
The action of P-glycoprotein in mediating the reduced 
intracellular drug accumulation associated with the MDR 
phenotype was clarified by the identification of 
extensive homology between P-glycoprotein and the Hyl-B 
protein, an E. coli membrane protein involved in the 
export of haemolysin (Gerlach et al., 1986). Both
protein sequences have multiple potential transmembrane 
segments consistent with channel forming functions. In 
addition the cytoplasmically located C-terminal regions 
of P-glycoprotein and Hyl-B are homologous to the 
nucleotide binding domains of four closely related 
bacterial ATP-binding proteins and it was proposed that 
P-glycoprotein functions in resistant cells as an energy 
dependent efflux pump to reduce intracellular drug 
levels.
The importance of P-glycoprotein in the MDR phenotype was 
supported by the observations that photoaffinity 
analogues of vinblastine will bind to P-glycoprotein and 
that this binding is competitively inhibited by 
anthracyclines and by vinblastine itself, although 
colchicine and actinomycin D do not compete for binding
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suggesting that there may be more than one binding site 
on P-glycoprotein (Cornwell et al. . 1986; Safa et al. .
1986; Cornwell, Gottesman and Pastan, 1986).
It has also been reported that other agents including 
verapamil and quinidine will also compete for binding 
(Cornwell, Pastan and Gottesman, 1987), and have been 
shown to be capable of restoring sensitivity in some MDR 
lines (Tsuruo et al.. 1983; Bellamy et al.. 1988b). This 
finding has led to their introduction into clinical 
trials in conjunction with cytotoxic chemotherapy in an 
attempt to circumvent drug resistance (Ozols et al., 
1987; Jones et al.. 1990).
1.5.5. The mdr gene family
The MDR phenotype has been linked to increased expression 
with or without amplification of the gene encoding P- 
glycoprotein (Shen et al.. 1986; Riordan, Deuchars and
Kartner, 1985). Several classes of P-glycoprotein cDNAs 
have been identified in hamster (Endicott et al., 1987), 
mouse (Gros, Croop and Housman, 1986) and human (Van der 
Bliek et al. . 1988) cells. It has been proposed that
varying expression of these different genes may affect 
the pattern of drug resistance (Moscow and Cowan, 1988). 
However in five human MDR lines, Van der Bliek et al. 
(1988) have confirmed the central role of the mdrl gene 
and found no over expression of other mdr genes to 
account for variations in cross resistance patterns.
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They suggest that changes in the mdrl gene itself, 
alternative splicing of mdrl pre-mRNA or alterations in 
unlinked genes may be responsible for the observed 
resistance.
The most striking evidence of the importance of P- 
glycoprotein in MDR has come from studies where mouse 
(Gros, Croop and Housman, 1986) and human (Ueda et al. . 
1987) mdrl cDNA sequences have been subcloned into 
expression vectors and transfected into drug sensitive 
cells. The expression of these genes in the recipient 
cells conferred the full MDR phenotype, and the relative 
drug resistance was found to have some correlation with 
the copy number of mdrl cDNA in the transfected cell 
line.
1.5.6. Clinical relevance of mdrl gene and P-glycoprotein
Using a DNA probe for the mdrl gene isolated from an MDR 
human KB carcinoma cell line, Fojo et al. (1987) have 
measured levels of mdrl mRNA in normal human tissues and 
in tumours. They found increased mdrl expression in 
adrenal and kidney tissues and to a lesser extent in 
other tissues including lung, liver and colon, with 
levels of mdrl mRNA in these organs being comparable to 
that of the MDR KB cell lines. When a series of 
predominantly untreated human tumours were probed it was 
noted that the majority of tumours arising from colon and 
adrenal also had high levels of expression, although in
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some other tumours arising from these tissues, levels of 
mdrl mRNA were no higher than that seen in the parent 
drug sensitive KB cell line which was used as a standard.
Salmon et al. (1989) have suggested that the presence of 
P-glycoprotein in human tumours does predict intrinsic 
cellular drug resistance. Using monoclonal antibodies to 
detect P-glycoprotein in 26 human tumour samples, they 
found that only 3 of 14 P-glycoprotein-negative tumours 
showed in vitro resistance to adriamycin, in contrast to 
all of 12 tumours which stained positively for P- 
glycoprotein
The role of mdrl and P-glycoprotein in normal tissues 
remains uncertain, although it has been suggested that in 
tissues such as colon, kidney and liver which are exposed 
to high levels of naturally occurring enviromental 
toxins, P-glycoprotein may have a protective function by 
promoting the efflux of these toxins from the cell 
(Kartner and Ling, 1989). The proposal is that this 
natural defence mechanism has been adopted to provide 
protection for cells against these cytotoxic drugs, all 
of which are naturally derived products.
1.5.7. Exocytosis as a drug efflux mechanism
There is recent evidence implicating increased 
exocytic/endocytic activity in the MDR phenotype 
(Sehested et al. . 1987a, 1987b). Using an
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ultrastructural morphometric technique to measure 
membrane area and cell compartmental volumes, a 
significantly increased membrane traffic between the 
plasma membrane and endosomal system has been observed in 
four MDR Erlich ascites tumour lines and a MDR P388 
murine leukemia line, compared to the sensitive parent 
lines.
It was proposed that this observation could account for 
the increased drug efflux in MDR cells by the trapping of 
drug in the endosomal system and subsequent exocytosis 
into the extracellular compartment. This hypothesis was 
supported by the finding that verapamil, which has been 
shown to inhibit active drug efflux in these cell lines 
(Kessel and Wilberding, 1985; Friche, Skovsgaard and 
Nissen, 1987), inhibited this increased plasma membrane 
traffic. They suggested that protonation of these basic 
drugs could account for drug trapping and concentration 
in the acid endosomal compartment.
This model of MDR does not, however, exclude a role for 
P-glycoprotein in this efflux mechanism. Cornwall, 
Gottesman and Pastan (1986) have reported that the 
binding of vinblastine by plasma membrane and endocytotic 
vesicles was increased in resistant KB cell lines and 
that this binding could be reduced by trypsin. Their 
conclusion was that drug binding to a protein receptor 
within the vesicles may be responsible for their drug
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accumulation. P-glycoprotein would clearly be a suitable 
candidate.
1.5.8. Evidence for other resistance mechanisms
Although the evidence supporting a major role for the 
mdrl gene and P-glycoprotein in resistance to this group 
of drugs is clear, a number of cell lines have been 
identified which display the classical MDR phenotype but 
show no increase in P-glycoprotein or reduction in drug 
accumulation (Danks, Yalowich and Beck, 1987; Marsh and 
Center, 1987). In addition, several studies have 
reported a lack of correlation between adriamycin 
accumulation and resistance ( Kessel and Corbett, 1985; 
Marsh, Sickieri and Center, 1986).
Kessel and Wilberding (1985) showed that when sensitive 
and MDR P388 leukemia cells were incubated at different 
extracellular daunorubicin concentrations designed to 
produce identical intracellular drug concentrations, the 
MDR cells remained more resistant than the sensitive 
cells to a given intracellular daunorubicin 
concentration.
Similarly, in their study of sensitive and MDR human 
myeloma lines, Bellamy et al. (1988a) have shown a direct 
relationship between intracellular drug accumulation and 
formation of single and double strand breaks and DNA- 
protein cross-links. However, at least at low adriamycin
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concentrations, there was no correlation between drug 
accumulation and cytotoxicity as assessed by clonogenic 
assay and they suggested that this might be explained by 
prolonged retention of drug by sensitive cells compared 
to resistant cells with a consequent increase in the 
amount of damage sustained by the sensitive cell. In a 
subsequent report (Bellamy et al., 1988b), they showed
the addition of verapamil blocked drug efflux in 
resistant cells and restored sensitivity.
It now seems likely that a number of other resistance 
mechanisms are possible and that in many cases the 
development of resistance is multifactorial in origin. 
These additional mechanisms would be expected to vary 
among the MDR group of drugs, depending on their 
particular mode of action.
It is worth considering at this point the proposed 
mechanisms of action of adriamycin, which is the main 
agent studied in this thesis. These include DNA 
intercalation, where the amino sugar portion of the drug 
binds to the sugar phosphate backbone of DNA, blocking 
synthesis of DNA, RNA and hence protein, and the 
interaction of the drug with the enzyme topoisomerase II 
(topo II) . A further mechanism is via the reduction of 
the drug by microsomal P450 reductase to a semiquinone 
free radical, which in turn produces highly reactive 
oxygen species which may be responsible for DNA strand 
breaks and damage to cytoplasmic constituents (Begleiter
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and Blair, 1984). Using adriamycin coupled to an 
insoluble agarose support, it has also been demonstrated 
that adriamycin can also exert its cytotoxic effect 
without entering cells (Tritton and Lee, 1982), and it is 
possible that membrane damage can contribute to
cytotoxicity.
1.5.9. Glutathione and related enzymes
The glutathione-S-transferases (GST) are a family of 
enzymes involved in drug detoxification by the
conjugation of the tripeptide, glutathione (GSH), to 
electrophilic compounds. GSH also detoxifies oxygen- 
induced free radicals, a reaction catalysed by
glutathione peroxidase. Increased intracellular levels 
of GSH, the substrate for both GST and glutathione 
peroxidase, are associated with resistance to adriamycin, 
as well as to melphalan and cisplatin (Green et al.,
1984). Depletion of intracellular GSH levels with
Buthionine sulfoxamine (BSO), which inhibits its
synthesis has been shown to reverse adriamycin resistance 
in V79 cells (Russo and Mitchell, 1985).
Further evidence of the importance of this group of 
enzymes has come from the work of Mimnaugh et al. (1989), 
who have shown that MDR MCF-7 human breast tumour cells 
have increased levels of enzymatic defences against 
reactive oxygen species. This group have subsequently
reported that treatment with BSO caused an 80-90%
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depletion in intracellular GSH content and resulted in a 
partial reversal of adriamycin resistance in this line, 
associated with an increase in drug-induced hydroxyl 
radical production (Dusre et al., 1989).
1.5.10. Topoisomerases
Topoisomerases are nuclear enzymes which catalyse changes 
in the secondary and tertiary structure of DNA. Most 
interest is centred on topoisomerase II (topo II) which 
catalyses transient double strand breaks to allow two 
double stranded DNA segments to pass during DNA 
replication or transcription. There is evidence that a 
number of drugs including anthracyclines and 
epipodophyllotoxins interact with topo II to stabilise 
the cleavable complex between the enzyme and DNA and thus 
increase the strand breaks produced (Tewey et al.. 1984). 
Increased drug resistance may therefore result from 
either reduction of cellular topo II levels or from an 
enzyme mutation resulting in reduced drug affinity of the 
enzyme. Altered topo II activity has been reported in an 
MDR CHO cell line (Glisson et al. , 1986) and an
adriamycin resistant P388 leukemia line (Deffie, Batra 
and Goldenberg, 1989), whilst Ferguson et al. (1988) have 
shown that resistance to etoposide in an MDR KB cell line 
appeared to result both from reduced accumulation of drug 
and from reduced levels of topo II.
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1.6. Resistance models
1.6.1. MDR and clinical response
There is considerable debate over the relevance of many 
of the models of drug resistance to the undoubtedly real 
problem of resistance as encountered in the clinic. 
Increased expression of mdrl or P-glycoprotein has been 
detected in a number of human tumours (Fojo et al. . 1987;
Salmon et al. . 1989; Goldstein et al. . 1989). Although
clarification of the extent of the relationship between 
mdrl and clinical response awaits further information, 
there is some evidence that high levels of mdrl 
expression may be associated with poor prognosis in 
neuroblastoma (Bourhis et al.. 1989) and soft tissue
sarcoma (Chan et al., 1990).
The in vitro phenomenon of MDR certainly mirrors a 
frequently observed clinical situation where on the
recurrence of tumour following previous drug treatment, 
the tumour is then refractory, not only to further 
treatment with the same drug but is also cross resistant 
to other drugs. Therefore, for any tumour type, the 
probability of a second response to cytotoxic
chemotherapy following relapse is very much less than 
that to the first line treatment.
Resistant cell lines are most commonly derived by in 
vitro exposure to levels of drug never encountered in the
36
therapeutic context, and can result in cell lines with 
greater than 100 or even 1000 fold resistance compared to 
the parent line. However, because toxicity to normal 
tissues limits the clinical use of these agents to a 
narrow dose range, even a two or three fold increase in 
resistance may potentially be sufficient to result in a 
failure of response in the clinical setting. Therefore 
the relevance of these highly resistant models to the 
clinical situation is uncertain. This consideration has 
been appreciated by several groups who have concentrated 
their efforts on the study of low levels of resistance 
(Hill, 1986; Lemont, Azarnia and Gross, 1988).
Although it is not yet clear whether the distinction 
between high and low levels of MDR is generally one of 
degree, there is evidence that the mechanism of 
resistance to methotrexate differs depending on the 
magnitude of resistance expressed (Hill, 1986). In 
addition, the method used to induce drug resistance can 
also affect the mechanism. It has been demonstrated that 
resistance to vincristine in a murine lymphoma cell line 
can be induced by prior exposure either to the drug 
itself or to radiation, and that both these methods 
resulted in independently derived lines which exhibited 
approximately 50-fold resistance to vincristine (Hill, 
Whelan and Bellamy, 1984). Although the drug exposed 
cell line displayed the characteristic MDR phenotype of 
reduced accumulation and cross resistance to a number of 
drugs, the radiation exposed line showed no change in
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drug accumulation and a different pattern of cross 
resistance.
1.6.2. Prediction of drug response
In their mathematical model of drug resistance Goldie and 
Coldman (1983) related the development of resistance in a 
tumour to the mutation rate of its stem cell compartment. 
The higher the mutation rate or the larger the tumour, 
the greater the probability that it would contain 
resistant cells. The model also predicts that tumours 
with a small stem cell compartment, and therefore slower 
growth, will have accumulated more resistant mutations in 
those stem cells at a given tumour size than tumours with 
a larger stem cell compartment. The model also supports 
the policy of earlier diagnosis or use of adjuvant 
chemotherapy, since the probability of the existence of 
resistant cells is lower, and therefore the likelihood of 
therapeutic success is higher in these smaller tumours, 
although if chemotherapy is unsuccessful, the mutagenic 
effects of the drugs may result in the increased 
production of new variants by survivors.
It is widely assumed that the presence of one or more 
resistant cells within a tumour is sufficient to result 
in ultimate therapeutic failure. It is proposed that 
following exposure to cytotoxic drugs the sensitive cells 
are killed resulting in tumour shrinkage. However the 
resistant cells survive and continue to divide and as a
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result of this selection come to dominate the tumour so 
that the tumour becomes progressively more resistant with 
time (Kartner and Ling, 1989). The existence of multiple 
subpopulations with varying sensitivities to different 
treatment provides the rationale for the use of 
combination therapies either of drugs or of mixed 
treatment modalities such as chemotherapy and 
radiotherapy.
This model assumes that sensitive and resistant cells 
within the tumour behave independently and that the drug 
response of any individual cell is not affected by the 
presence of its neighbours. However several groups have 
suggested this may not be the case but that interaction 
between sensitive and resistant populations within the 
tumour may alter the ultimate drug response.
1.7. Interaction of sensitive and resistant cells
1.7.1. Transfer of drug resistance
The most striking evidence of such an interaction was 
reported by Tofilon and colleagues who studied the 
response to 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) 
of rat brain tumour cells grown as spheroids (Tofilon, 
Buckley and Deen, 1984; Tofilon, Arundel and Deen, 1987). 
They found that when measured by cell survival and 
spheroid growth delay assays, spheroids composed of mixed 
BCNU sensitive and resistant cells were more resistant
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than that predicted from the sensitivities of purely 
sensitive or resistant spheroids.
To identify the individual drug response of the two 
subpopulations in mixed spheroids they used the number of 
drug-induced sister chromatid exchanges (SCE) within the 
cells both as an index of DNA damage and cytotoxicity, 
and also to identify the resistant and sensitive 
populations. Fewer SCEs were sustained by resistant 
compared to sensitive cells when exposed to drug 
individually, and this difference between the two groups 
allowed them to be distinguished in mixed culture. They 
found a proportionate decrease in the number of SCEs 
sustained by the sensitive cells as the proportion of 
resistant cells within the mixed spheroids was increased. 
However, when the spheroids were disaggregated into 
single cells before drug exposure, there was no decrease 
in the number of SCEs induced in the sensitive cells, the 
level instead remaining comparable to that found in 
spheroids grown from sensitive cells alone.
In contrast, when the two cell types were grown in mixed 
monolayer culture there was no resistance transfer and 
they suggested that the interaction was dependent on the 
three dimensional contact afforded by spheroid geometry. 
However Bradford et al. (1986) did not find a three 
dimensional relationship essential for the occurrence of 
this phenomenon. In a preliminary report they described 
a similar interaction between vincristine/vindesine
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resistant and sensitive clones of a spontaneous murine 
astrocytoma in monolayer culture. They found that a 
mixed culture produced from equal numbers of sensitive 
and resistant cells adopted the chemosensitivity of the 
more resistant line, suggesting possible resistance 
transfer.
1.7.2. Transfer of drug sensitivity
Miller, Miller and Heppner (1981) have demonstrated that 
interaction between sensitive and resistant cells does 
not even always require cell to cell contact. By
culturing methotrexate sensitive and resistant mouse
mammary tumour lines on separate cover slips within the 
same dish they observed reduced survival of the resistant 
cells following drug exposure. They also showed that the 
simultaneous presence of the sensitive cells in the dish 
was required to produce this interaction as growth of the 
resistant line in medium conditioned by the sensitive 
line had no effect. They suggested that this implicated 
the transfer of a labile mediator in this phenomenon. A
second resistant line, however, failed to show any
interaction.
In the same report this group also demonstrated 
interaction of mammary tumour lines in vivo. Following 
injection of syngeneic mice on opposite flanks with 
cyclophosphamide sensitive and resistant cells they found 
that drug induced growth delay in the resistant line was
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increased by the presence of the sensitive tumour line on 
the opposite flank but not by a second resistant tumour. 
On this occasion the proposed mechanism of interaction 
was by increased drug activation in mice bearing the 
sensitive line.
It is therefore evident that, depending on the cell 
types, model system and drug studied, the interaction 
between populations can produce a shift towards either 
sensitivity or resistance. Although these studies 
describe interactions between only two subpopulations 
they may be considered representative of the multiple 
interactions possible between the large number of 
subpopulations present in a heterogenous tumour (Itaya et 
al., 1989).
1.7.3. Junctional communication in interactions
It is not clear in the earlier examples of interaction 
involving direct cell contact whether intercellular 
communication through gap junctions may be involved. The 
property of metabolic cooperation within a coupled 
population has been shown to be responsible for transfer 
of drug sensitivity or resistance in other situations.
Intercellular transfer of nucleotides is responsible for 
interaction between normal and HGPRT-negative cells with 
respect to 6-thioguanine sensitivity. Fujimoto et al. 
(1971) demonstrated that HGPRT-negative fibroblasts
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established from skin biopsies from patients with the 
Lesch-Nyhan syndrome were resistant to the drug when 
cultured on their own, but in mixed culture with normal 
(HGPRT-positive) cells, the transfer of thioguanine 
nucleotides via gap junctions from normal to HGPRT- 
negative cells conferred sensitivity on the mutant line.
Ouabain exerts its cytotoxic effects by inhibition of 
Na+/K+ ATPase, thus blocking Na+/K+ fluxes across the 
membrane necessary to maintain cellular ionic balance. 
Rodent cells are inherently more resistant to the effects 
of ouabain on account of a reduced affinity of their 
enzyme for the drug. Corsaro and Migeon (1977) have 
shown that when a mixed culture of human and mouse 
fibroblasts were exposed to a ouabain concentration 
adequate to inhibit division of human but not mouse cells 
on their own, the human cells continued to proliferate. 
They proposed that this protection of the human cells by 
mouse cells was the result of intercellular transfer of 
Na+ and K+ along diffusion gradients between the 
cytoplasms of the two cells. Avoidance of cell to cell 
contact by growing the two cells lines on separate cover 
slips within the same dish, or the use of mouse L cells 
which do not communicate through gap junctions abolished 
this effect, indicating the fundamental role of 
junctional intercellular communication in this 
phenomenon.
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1.7.4. A model of interaction between sensitive and MDR 
cell lines
As the above example demonstrates, where the cytotoxicity 
of a drug is dependent on the cytoplasmic concentration 
of a small molecule or ion, the ability of this molecule 
to pass freely from cell to cell along diffusion 
gradients enables equilibrium to be approached within the 
coupled population. Consequently the tendancy towards 
homogeneity afforded to the population by the junctional 
channels is translated into a more uniform response to 
the drug.
In general, therefore, if there were resistant cells 
within the population whose ability to survive drug 
exposure was dependent on their capacity to regulate the 
cytoplasmic concentration of this molecule within 
tolerable limits, then the coupling of these cells to 
adjacent sensitive cells which did not posess this 
regulatory capacity might enable the resistant cells to 
rescue the sensitive cells by means of their shared pools 
of small cytoplasmic molecules.
An analogy can be drawn between the mechanism of ouabain 
resistance and that of the MDR phenotype mediated by P- 
glycoprotein. In both instances resistance is dependent 
on the adequate functioning of a membrane pump. In the 
case of MDR it is the intracellular concentration of the 
drug itself rather than of ions or intermediary
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metabolites which appears to be the crucial factor 
governing cytotoxicity. The molecular weight of many 
drugs is small enough to allow them to pass freely 
through gap junctions, which suggests the possibility of 
rescue of a sensitive cell by an adjacent resistant cell 
if the P-glycoprotein pump in the resistant cell was able 
to reduce the intracellular drug concentration of both.
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1.8. Summary and objectives
Intercellular communication through gap junctions may 
affect cellular response to radiation, cytokines or 
cytotoxic drugs in a number of ways.
There is good evidence that junctional communication 
affects radiation and lymphokine response, although there 
is no present data on its possible role in the increased 
resistance to cytotoxic drugs observed in spheroid 
compared to monolayer culture. The mechanism through 
which junctional communication may influence resistance 
to these different modalities is unknown. One
possibility is that if random damage from either 
radiation, lymphokines or cytotoxic drugs produces a 
variety of metabolic defects within different cells, then 
in a coupled population some form of mutual support of 
defective cells such as that shown in the metabolic 
cooperation studies of Subak-Sharpe et al. (1966) could 
be responsible.
There is also evidence that intercellular communication 
is involved in some examples of interactions between drug 
sensitive and resistant cells. As discussed in the above 
model (section 1.7.4.), it is possible that interactions 
of sensitive and MDR populations may occur via junctional 
transfer of drug.
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The principal objectives of this present study are:
1. To determine whether the correlation between 
junctional communication and cellular resistance to 
radiation and the lymphokines, lymphotoxin and tumour 
necrosis factor, can be extended to include conventional 
cytotoxic drugs.
2. To investigate whether transfer of drug resistance can 
be demonstrated between sensitive and multidrug resistant 
cells in mixed culture.
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Chapter 2 MATERIALS AND METHODS
2.1. Materials
2.1.1. Radiochemicals
3H uridine (lmCi/ml) and 3H thymidine (lmCi/ml) were 
purchased from Amersham International pic.
2.1.2. Drugs
Adriamycin (doxorubicin) (Farmitalia Carlo Erba Ltd.), 
mitozantrone (Lederle Ltd.), vincristine and vindesine 
(Eli Lilly and Co. Ltd.) were solubilised according to 
manufacturers' instructions for injection and then stored 
as frozen aliquots at -20°C until required.
2.1.3. Fluorescent dyes
Lucifer yellow and rhodamine isothiocyanate-dextran were 
obtained from Sigma Chemical Company. Adriamycin for 
microinjection studies was also obtained from Sigma 
Chemical Company. Stock solutions were prepared in PBS 
and stored in darkness at 4°C until required.
2.1.4. Chemicals
Potassium ferricyanide, potassium ferrocyanide, 4-chloro- 
5-bromo-3indolyl-fi-galactosidase (X-gal), 3-(4,5-
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dimethylthiazol-2-yl)-2 ,5 diphenyltetrazolium bromide 
(MTT) were obtained from Sigma Chemical Company. 
Trichloracetic acid (TCA) was obtained from Koch-Light 
Laboratories.
Ilford L4 emulsion gel and Hypam fixative were obtained
from Ilford Ltd. D19 developer solution was obtained
from Kodak Ltd.
All other chemicals were obtained from British Drug 
Houses (BDH), Analar grade.
2.1.5. Tissue culture media
Hams F10 medium, PBS, BSS and all supplements were
obtained from Gibco Ltd. RPMI 1640 medium, Glasgow 
modified Eagle's medium and Foetal calf serum were 
obtained from Northumbria Biologicals Ltd.
2.1.6. Tissue culture dishes
25cm2 and 75cm2 flasks were obtained from Sterilin Ltd. 
3.5cm, 6cm and 10cm diameter Petri dishes were obtained 
from Becton Dickinson and Company, and 24 and 96 well 
plates from Costar Ltd.
Glass microscope slides and coverslips were obtained from 
Chance Propper Ltd.
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2.1.7. Cell lines
The following cell lines were studied:
1. Human non small cell lung cancer (NSCLC).
Seven different lines were studied, kindly provided by
Dr. R.I. Freshney, Glasgow. Histological and other
details are listed in table 1.
2. Murine astrocytoma.
These lines were kindly provided by Dr. J. Darling,
London. They comprised two clonal lines, designated C12 
and FI, derived from the P497 cell line, originally 
isolated from a spontaneous murine astrocytoma (Bradford 
et al, 1986).
3. Chinese hamster ovary (CHO).
CH0-K1 originally derived as a sub clone from
parental CHO initiated from a biopsy from 
the ovary of an adult Chinese hamster.
Adrr multidrug resistant line produced by growth of
CH0-K1 in adriamycin containing medium.
ADR-6 drug hypersensitive line obtained following
exposure of CH0-K1 to the mutagen ethyl 
methanesulphonate.
These lines (Chatterjee and Harris, 1990; I. Hickson,
unpublished) were kindly provided by Dr. I. Hickson,
University of Newcastle upon Tyne.
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Cell line Pathology/Source
A549
Calu-3
L-DAN
NCI-H23
NCI-H125
SK-MES-1
WIL
Table 1
Characteristics of 
Adapted from Merry
Bronchio-alveolar carcinoma 
American Type Culture Collection, USA
Adenocarcinoma
American Type Culture Collection, USA
Squamous carcinoma
Medical Oncology, Glasgow, UK
Adenocarcinoma
National Cancer Institute, USA 
Adenocarcinoma
National Cancer Institute, USA 
Squamous carcinoma
American Type Culture Collection, USA 
Adenocarcinoma
Ludwig Institute, Sutton, UK
NSCLC cell lines 
et al., 1987
CH0-K1-BG marked line following transfection of parent 
line (CH0-K1) with B-gal (section 4.3.4.).
4. Virus producer lines.
These lines were kindly provided by Dr. R. Brown, 
Glasgow. They comprised G4-12.2-YZ (Price, Turner and 
Cepko, 1987) and PZ-NC1 (Brown and Mee, unpublished).
5. Rat liver epithelial cell line (BRL).
This cell line was kindly provided by Dr. J.D. Pitts, 
Glasgow .
2.1.8. Vectors for DNA transfection
These recombinant vectors were kindly provided by by Dr. 
R. Brown, Glasgow. They comprised BAG (Price, Turner and 
Cepko, 1987) and pLGV^ (Debenham and Thacker, 
unpublished). Both contain the B-galactosidase gene, 
together with neo, which codes for resistance to the 
aminoglycoside G418, to allow selection of the marked 
line.
2.1.9. Solutions
1. Formol saline
The solution comprised 0.08M NaCl, 0.2M Na2S(>4 in 4% w/v 
formaldehyde in water.
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2. 13-galactosidase staining solution
This solution comprised lmg/ml X-gal, 5/xM potassium 
ferricyanide, 5/xM potassium ferrocyanide and 2mM MgCl2 in 
PBS.
2.2. Tissue culture methods
All cell lines were maintained in monolayer culture at 
37°C. Stock cultures were maintained in exponential 
growth in plastic tissue culture flasks. The growth 
medium was replenished every 3-4 days and the cells were 
subcultured every 5-10 days depending on growth rate by 
trypsinising (section 2.2.3.) the monolayers to yield a 
single cell suspension and transferring an aliquot of 
this suspension to a new flask containing fresh growth 
medium. After 3 months of continuous growth, cells were 
discarded and culture was restarted from cells stored in 
liquid nitrogen. Cell lines were periodically monitored 
for mycoplasma infection By staining with Hoescht 33258 
stain and were consistently negative.
2.2.1. NSCLC lines
NCI-H23 was grown in RPMI 1640 medium, supplemented by 
2mM glutamine, 1M pyruvate, non-essential amino acids, Na 
bicarbonate and 10% foetal calf serum. All other cell 
lines were grown in Hams F10 medium supplemented by 2mM 
glutamine, 1M pyruvate, 20mM Hepes buffer, non-essential 
amino acids, Na bicarbonate and 10% foetal calf serum.
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Cells were grown in air in routine culture but for 
nucleotide transfer and clonogenic assay experiments they 
were transferred to a humidified atmosphere of 
5%C(>2/95%air, and for MTT assays to an atmosphere of 
2%C02/98%air.
2.2.2. Murine astrocytoma and CHO lines
All lines were grown in Hams F10 medium supplemented by 
2mM glutamine, 1M pyruvate, 20mM Hepes buffer, non- 
essential amino acids, Na bicarbonate and 10% foetal calf 
serum in a humidified atmosphere of 5%C02/95%air.
2.2.3. Trypsinisation
Following removal of growth medium by suction, 0.25% 
trypsin solution was added (3ml to a 25cm flask; 5ml to 
a 75cm2 flask) for 30 seconds and then removed by 
suction. The flask was then incubated at 37°C until the 
cells were seen to round up, and detach from the surface 
of the dish. Fresh medium was then added and the culture 
dispersed into a single cell suspension by repeated 
pipetting. The cell density of the suspension could be 
assessed by measurement of cell number on an automatic 
counter (model "Industrial D", Coulter Electronics Ltd., 
Luton, UK).
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2.2.4. Preparation of base-coated flasks
lg agar was added to 20ml distilled H2O in a glass 
universal container and boiled until agar was completely 
dissolved. This solution was then added to 60ml growth
medium (preheated to 37°C) and gently mixed. 5ml aliquots
. . .  0were immediately pipetted to cover the base of 25cnr
flasks. On cooling at room temperature, the agar would 
set in approximately 5 minutes.
2.2.5. Preparation of spheroids
Stock cultures growing as monolayer were trypsinised and 
counted as above. 5 x 105 cells were added to each base- 
coated flask (BCF) in a total volume of 5ml medium and 
incubated in a humidified atmosphere of 5% CO2 / 95% air 
at 37°C. Within 2-3 days small floating aggregations of 
cells were visible which grew steadily to form spheroids. 
For most experiments 6-7 day old spheroids were used. 
There was often considerable variation in size, shape and 
compactness of the spheroids at this stage , but with 
practise and the aid of a dissecting microscope spheroids 
of reasonably uniform diameter of 200-300nm could be 
selected by eye and picked off from the dish with a 
Pasteur pipette.
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2.2.6. Autoradiography
5ml Ilford L4 emulsion gel was melted in a waterbath at 
47°C and diluted to 15ml with distilled H2O. Microscope
slides mounted with coverslips were dipped in the
emulsion, drained to remove excess emulsion and dried in 
a stream of cold air. The slides were placed in a light­
tight box and stored at 4°C for the appropriate period of 
exposure. They were then immersed in D19 developer
solution for 5 minutes, washed briefly in H2O and fixed
in Hypam for 4 minutes. After washing in running tap 
water for 5 minutes, the slides were stained in 5% Giemsa 
for 1 minute, then washed again with tap water and 
finally with distilled H2O. They were dried in air and 
glass coverslips were mounted with DePeX mountant.
2.2.7. Nucleotide transfer
This technique is a modification of the method originally 
described by Pitts and Simms (1977) and involves
T , , ,
measurement of the transfer of H u n d m e  nucleotides 
from labelled donor cells to unlabelled recipient cells. 
For each cell type, three 35mm petri dishes were
prepared. Two dishes contained 4 sterile 13mm diameter
plastic coverslips (recipient dishes) whilst one was
empty (donor dish) . Cells were plated (105 or 2 x 105
cells/dish) in 2ml medium into each dish. After 24 hours
incubation the donor cells were labelled with 20juCi H
uridine for 2 hours and then washed 4 times with medium
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to remove excess 3H uridine. They were then trypsinised 
and resuspended in 1ml medium and 400/xl aliquots were 
added to each of the recipient dishes. One of the 
resulting mixed dishes was incubated for 1.5 hours and 
the other for 3 hours. The medium was then removed, the 
dishes were washed 4 times in PBS, once in formol-saline 
and then fixed in formol-saline for 30 minutes. The 
coverslips were removed, placed in racks, washed twice in 
ice-cold 5% TCA, twice in ice-cold H2O and rinsed in 
ethanol. Once dry, the coverslips were mounted, cells 
uppermost, on microscope slides with DePeX and processed 
for autoradiography (section 2.2.6.). After development 
and staining a second coverslip was mounted on top with 
DePeX.
For quantitative analysis of the extent of incorporation 
of transferred labelled nucleotides, the coverslip was 
randomly scanned and the number of autoradiographic 
grains were counted over 3 0 consecutively observed 
recipient cells in contact with donor cells (touching 
cells) and over 30 recipient cells clearly separated from 
donor cells (background cells). The microscopical images 
from a Leitz Orthoplan microscope were displayed on a 
television monitor and grain counts over the selected 
cells obtained using a Micromeasurements Ltd System III 
image analyser.
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2.3. NSCLC chemosensitivity assays
2.3.1. Clonogenic assay: monolayer
2 .3.1 .1. 24 hour drug exposure
Exponentially growing cells were trypsinised and 
resuspended in medium to a concentration of 5 x 104 
cells/ml. 5 xlO3 cells/well (100/il) were seeded into a 
96 well microtitration plate and incubated overnight at 
37°C. The medium was then removed and replaced with fresh 
medium containing serial dilutions of adriamycin. For 
each cell type there were two control wells without drug. 
After incubation for 24 hours the medium and drug were 
removed, the wells were washed twice with 100/il medium 
and 50/xl/well trypsin was added. After 10 minutes a 
further 150/xl/well of medium was added to neutralise the 
trypsin and the cells were separated to a single cell 
suspension by repeated pipetting. 20/tl aliquots from 
each well were then added to 25cm2 flasks, each 
containing 5ml medium. After incubation for 11-28 days 
depending on the growth rate of the cell line the 
resulting colonies were fixed in methanol and stained 
with 10% Giemsa. Colonies > 50 cells were counted and 
expressed as a percentage of control. The concentration 
of drug which reduced the number of surviving colonies to 
50% of control (IC50) was determined graphically.
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2 . 3 .1.2 . 72 hour drug exposure
The method was identical to that above with the 
exceptions that NCI-H23 were seeded at 2 x 103 cells/well 
and L-DAN at 103 cells/well. Triplicate wells were 
prepared at each drug concentration. The duration of 
drug exposure was 72 hours with replenishment of medium 
and drug at 24 and 48 hours.
2.3.2. MTT assay
Exponentially growing cells were trypsinised and 
resuspended in medium. 103 cells/well in 200fil medium 
were seeded into 96 well microtitration plates (increased 
to 2.5 x 103 and 5 x 103 cells/well for NCI-H125 and 
Calu-3 respectively in view of their slower growth rate). 
The plates were then incubated at 37°C for 3 days.
On the fourth day the medium was removed and replaced 
with fresh medium containing serial adriamycin dilutions. 
There was a control column without drug at each end of 
the plate, whilst the first and last columns contained 
medium alone and were used to blank the plate reader. 
All drug concentrations and standards were tested on 8 
replicate wells on each plate. After 24 hours incubation 
the medium and drug were removed and replaced with fresh 
medium, the cells were also fed with fresh medium on each 
of the next two days.
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On the fourth day following drug exposure the cells were 
again fed with fresh medium, on this occasion with the 
addition of lOmmol hepes buffer. 50/ul/well of MTT was 
then added (4.5mg/ml of a solution prepared in PBS), the 
plates were wrapped in tin foil to protect them from 
light and they were incubated for a further 4 hours. The 
medium was then removed and the MTT formazan crystals 
dissolved in 200/il dimethyl sulphonate (DMSO) . 25/il of
0.1M tris buffer was added to each well and the plates 
were read on an ELISA plate reader at an absorbance of 
570nm. The concentration of drug which produced half the 
absorbance of the control wells (IC50) was determined 
graphically for each cell line.
2.3.3. Clonogenic assay: spheroid
In view of their differing growth characteristics, in 
order to produce speroids of equivalent size 5-6 day old 
L-DAN spheroids and 6-8 day old SK-MES-1 spheroids were 
used in assays.
1.25ml medium containing serial adriamycin dilutions was 
added to 25cm base-coated flasks (BCF) containing 5ml 
medium and spheroids. Medium alone was added to a 
control flask. Following 24 hours incubation at 37°C the 
medium and spheroids from each flask were transferred by 
pipette to 60 mm diameter petri dishes. Using a 
dissecting microscope 10 spheroids of 200-300nm diameter 
were selected from each dish by eye, picked off with a
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pasteur pipette and transferred to one well of a 24 well 
microtitration dish. 0.5ml of 0.25% trypsin solution was 
added to each well and the dish was incubated at 37°C for 
10 minutes. The spheroids were disaggregated to a single 
cell suspension by repeated pipetting and 1.5ml of medium 
added to each well to neutralise the trypsin. 200jul 
aliquots of this suspension were then added in triplicate 
to new 25cm2 flasks containing 4ml medium and incubated 
at 37°C. The resulting colonies were fixed in methanol 
and stained with 10% Giemsa. Colonies > 50 cells were 
counted and expressed as a percentage of control. The 
IC50 was calculated as before.
2.4. Murine astrocytoma cell lines
2.4.1. Clonogenic assay
Exponentially growing cells were trypsinised and 
resuspended in medium. 2 x 104 or 105 cells/well in 2ml 
medium were added to a 24 well microtitration plate. 
After 24 hours incubation at 37°C, the medium was removed 
and and replaced with fresh medium containing
dilutions. One set of wells contained medium alone and 
acted as control.
Following a further 24 hours incubation, the medium and 
drug were removed and 200/zl 0.25% trypsin solution was 
added to each well. After 10 minutes incubation 
1.8ml/well of medium was added to neutralise the trypsin
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and the cells separated to a single cell suspension by 
repeated pipetting. 400jil aliquots from each well were 
then counted on a Coulter counter and, after dilution in 
medium, 5 x 102 cells/well were plated into triplicate
60mm Petri dishes each containing 4ml medium.
The dishes were incubated at 37°C for 8 days, fixed in 
methanol and then stained with 10% Giemsa. Colonies > 50 
cells were counted and expressed as a percentage of 
control.
2.4.2. Genetic marking with B-galactosidase
Exponentially growing recipient lines were trypinised and 
resuspended in medium. For each cell line, 5 x 105 cells
were plated into each of four 75cm2 flasks in 15ml
. . omedium. Concurrently the medium was removed from a 75cm
flask containing a subconfluent monolayer of virus
producer cells and replaced with 15ml fresh medium.
After 24 hours incubation at 37°C medium was removed from
both virus producer and recipient flasks and a mixture of
470/xl fresh culture medium, 30/xl of 0.8mg/ml solution of
polybrene in PBS and 500/il medium from virus producer
cell flasks (after passing through a 0 .2/xm filter) were
added to each recipient flask. After incubation at 37°C
for two hours a further 6ml of non selective medium was
added to each flask.
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After 72 hours incubation and growth, medium was removed 
and cells were trypinised and resuspended in medium. 
Selection of infected cells was commenced by plating 5 x 
105 cells from each flask into each of two 10cm Petri
dishes containing 15ml medium with lmg/ml G418. The
. . .  • oviability of cells was also checked by plating 2 x 10
cells into 10cm dishes containing 15ml non selective
medium. The plates were incubated at 37°C for 2-3 weeks
with weekly replenishment of medium and G418 to allow
growth of colonies of infected cells.
2.5. CHO cell lines
2.5.1 Clonogenic assay
Exponentially growing cells were trypsinised and 
resuspended in medium to a concentration of 5 x 104 
cells/ml. 5 x 103 cells (100/xl) were then added to each 
well of a 96 well microtitration plate. After overnight 
incubation at 37°C the medium was removed and replaced 
with fresh medium containing serial adriamycin dilutions 
in triplicate. For each cell type there were also
triplicate control wells without drug. The plates were 
incubated for 24 hours then the medium was removed and 
50/xl/well of trypsin added. After a further 10 minutes 
incubation 150jli1 medium was added to neutralise the 
trypsin and the cells were separated to a single cell 
suspension by repeated pipetting. 20/il aliquots from 
each well were then added to 25cm2 flasks, each
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containing 4ml medium. The flasks were incubated for 7 
days at 37°Cf fixed in methanol and stained with 10% 
Giemsa. Colonies > 50 cells were counted and expressed 
as a percentage of control. The IC50 was calculated as 
before.
2.5.2. Growth rate
Exponentally growing monolayers were trypsinised and 
resuspended in medium. For each cell type 104 cells were 
plated into each of 14 replicate 35mm diameter Petri 
dishes in a total volume of 3ml medium/dish and incubated 
at 37°C to allow growth of cells. The total cell number 
per dish was estimated at regular intervals by 
trypsinisation of paired dishes at each time point and 
counting the resulting single cell suspension on a
coulter counter. After the third day of growth the 
medium was replenished every 24 hours. The doubling time 
was calculated as the time taken for the cell number to 
increase two-fold at maximum growth rate.
2.5.3. 3H thymidine incorporation: coculture of CH0-K1- 
BG and Adrr
Exponentially growing cells were trypsinised and
resuspended in medium. They were then seeded into 35mm
diameter Petri dishes, each containing 3 x 13mm sterile
glass coverslips. Three sets of dishes were prepared: 
one containing Adrr cells alone, one with CH0-K1 cells
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alone and one with a 50:50 mixture of the two cell types. 
Cell density in a series of experiments varied from 105 
to 106 cells per dish in 2ml medium. Following 2 hours 
incubation at 37°C to allow attachment of the cells to 
the dish, 1ml medium containing serial dilutions of 
adriamycin at 3 times the final concentration was added. 
A set of control dishes without drug were included. 
After a further 24 hours incubation the drug and medium 
were removed and replaced with fresh medium.
. • 1 t •The dishes were labelled for 24 hours with H thymidine 
(200/uCi/ml in PBS, 50/ul/dish) either concurrently with 
the period of drug exposure on the first day of the 
assay, or alternatively, following a further period of 
incubation, on either the second, third or fourth day of 
the assay. Following labelling the medium was removed, 
the dishes washed twice with PBS, once with formol-saline 
and then fixed in formol-saline for 30 minutes. The 
coverslips were then transferred to racks, washed twice 
with ice-cold 5% TCA, twice with ice-cold H2O and rinsed 
in ethanol. The coverslips were then used either for 
autoradiography or scintillation counting (see below).
2.5.3.1. Autoradiography
One of the coverslips from each dish was mounted (cells 
uppermost) on microscope slides with DePeX and processed 
for autoradiography (section 2.2.6.). After 1-2 days 
exposure the slides were developed, fixed and stained
with 10% Giemsa, and a second covers lip mounted on top 
with DePeX. The coverslips were examined
microscopically. 500 cells consecutively observed on 
randomly scanning the coverslip were studied and the 
number of cells exhibiting photographic grains over their 
nucleus indicative of incorporation of label were 
counted. The labelling index (LI) was calculated as 
follows:
LI = number of labelled cells x 100
total number of labelled and unlabelled cells
2.5.3.2. Scintillation counting
Coverslips from each dish, selected as having the most 
even cell distribution, were added individually to 
scintillation vials each containing 5ml scintillant and 
counted for 1 minute on a liquid scintillation counter 
(model 1217 Rackbeta, LKB Wallac). The counts for each 
coverslip were expressed as a percentage of control for 
each set of dishes, Adrr alone, CHO-K1 alone and mixed, 
and plotted against adriamycin concentration. In the 
majority of experiments there were two coverslips at each 
drug concentration and the mean of the two counts was 
plotted.
In later studies, to avoid any variability caused by 
uneven distribution of cells between dish and coverslips, 
and in order that the incorporation of label over the
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entire dish could be assessed, the cells were seeded into 
dishes without coverslips. The dose of label on this 
occasion was 50/xl of 40/xCi/ml 3H thymidine in PBS. 
Following TCA extraction the cells were solublised in 2ml 
0.1M NaOH for 15 minutes, then acidified with 0.3ml 1M 
HC1, added to scintillation vials with 5ml scintillant 
and counted as before.
2.5.4. Genetic marking of cells with B-galactosidase
2.5.4.1. DNA transfection
Exponentially growing recipient cells were trypsinised 
and resuspended in medium. For each cell line 106 cells 
were added to each of two 75cm2 flasks in 15ml medium. 
After incubation for 20 hours the medium was removed and 
replaced with fresh medium.
5 /xcf of plasmid DNA and 15/ig of carrier DNA (55/zl volume) 
were added to 380/zl distilled H2O and 60|il of 2.5M CaCl2 
and mixed on ice. This was then added dropwise to 500/il 
of 2 x Hepes buffered saline in a Falcon 2058 tube and 
mixed by air bubbling. The mixture was left for 60min at 
room temperature, then 500/xl was added to each recipient 
cell flask and mixed gently to distribute evenly.
After incubation at 37°C for 72 hours, the medium was 
removed from the flasks, and the cells trypsinised and 
resuspended in medium. Selection of transfected cells
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was commenced by plating 5 x 105 cells from each flask 
into each of two 10cm Petri dishes containing 15ml medium 
with lmg/ml G418. The viability of cells was also 
checked by plating 2 x 102 cells into 10cm dishes 
containing 15ml non selective medium. The dishes were 
incubated at 37°C for 2-3 weeks with weekly replenishment 
of medium and G418 to allow growth of colonies of 
transfected cells.
2.5.4.2. Retroviral Infection.
Exponentially growing recipient lines were trypinised and 
resuspended in medium. For each cell line, 5 x 105 cells 
were plated into each of four 75cm2 flasks in 15ml 
medium. Concurrently the medium was removed from a 75cm2 
flask containing a subconfluent monolayer of virus 
producer cells and replaced with 15ml fresh medium. 
After 24 hours incubation at 37°C medium was removed from 
both virus producer and recipient flasks and a mixture of 
470/il fresh culture medium, 30/xl of 0.8mg/ml solution of 
polybrene in PBS and 500/xl medium from virus producer 
cell flasks (after passing through a 0 .2jum filter) were 
added to each recipient flask. After incubation at 37°C 
for two hours a further 6ml of non selective medium was 
added to each flask.
After 72 hours incubation and growth, medium was removed 
and cells were trypinised and resuspended in medium. 
Selection of infected cells was commenced by plating 5 x
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105 cells from each flask into each of two 10cm Petri 
dishes containing 15ml medium with lmg/ml G418. The 
viability of cells was also checked by plating 2 x 102 
cells into 10cm dishes containing 15ml non selective 
medium. The plates were incubated at 37°C for 2-3 weeks 
with weekly replenishment of medium and G418 to allow 
growth of colonies of infected cells.
2.5.4.3. G418 Titration
For each cell line, exponentially growing cells were 
trypinised and resuspended in medium and 2 x 102 cells 
plated into 25cm2 flasks containing 5ml medium with 
serial dilutions of G418. One flask contained medium 
alone and acted as control. Flasks were incubated at 
37°C for 7-10 days, then medium removed, fixed in 
methanol, stained with 10% Giemsa and colonies > 50 cells 
counted.
2 .5.4.4. 6-galactosidase staining
Medium was removed from monolayer cultures and dishes 
rinsed with PBS. Cells were then fixed for 10 mins at 
4°C in a solution of 2% formaldehyde and 0.2% 
glutaraldehyde in PBS. Fixative was then removed, cells 
were rinsed in PBS and staining solution (section 2.1.9.) 
added (3ml for 60mm dish or 25cm2 flask) . Dishes were 
incubated overnight at 37°C, staining solution removed, 
rinsed in PBS then in distilled H2O and dried in air.
68
2.5.5. CHO monolayer coculture
Exponentially growing cells were trypsinised and 
resuspended in medium. 105 cells/well were added to a 24 
well microtitration plate in 2ml medium. Three sets of 
wells were prepared: one containing each cell line on its 
own and one set containing a 50:50 mixture of the 
appropriate two cell types (CHO-K1-BG and Adrr for 
adriamycin and mitozantrone assays; CHO-K1-BG and ADR-6 
for vincristine assays).
The plate was incubated at 37°C for 24 hours, then the 
medium was removed and replaced with fresh medium 
containing serial dilutions of drug. For each set of 
wells, one well contained medium alone and acted as 
control. Following a further 24 hours incubation, the 
medium and drug were removed and 200/ul 0.25% trypsin
solution was added to each well. After 10 minutes 
incubation 1.8ml/well of medium was added to neutralise 
the trypsin and the cells separated to a single cell 
suspension by repeated pipetting. 400/nl aliquots from 
each well were then counted on a Coulter counter and, 
after dilution in medium, 5 x 102 cells/well were plated 
into triplicate 60mm petri dishes each containing 4ml 
medium.
The dishes were incubated at 37°C for 7 days and then 
stained for B-galactosidase (section 2.5.4.4.). Colonies 
> 50 cells were counted and expressed as a percentage of
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control. Marked CH0-K1-BG cells could be readily 
identified by their blue staining and in those dishes 
derived from mixed culture the number of marked and 
unstained colonies could be counted separately. In 
dishes derived from CHO-K1-BG alone, the number of 
colonies showing positive staining for B-gal as a 
fraction of the total number of colonies could also be 
calculated.
2.5.6. CHO spheroid coculture
2.5.6.1. Assessment of optimum initial ratio of CH0-K1- 
BG and Adrr to produce mixed spheroids
Base coated flasks were prepared with 5 x 105 cells as 
before to initiate spheroid formation. Duplicate flasks 
were prepared containing CH0-K1-BG cells alone and with 
ratios of CH0-K1-BG : Adrr of 1:1, 1:4, 1:8 and 1:12 and 
incubated at 37°C for 6 days to allow spheroid formation 
and growth.
The medium and spheroids from each flask were then 
transferred to 60mm Petri dishes. Under a dissecting 
microscope 10 spheroids of 200-300nm diameter were 
selected from each dish by eye, picked off with a Pasteur 
pipette and transferred to one well of a 24 well 
microtitration plate. 0.5ml of 0.25% trypsin solution 
was then added to each well and the plate was incubated 
at 37°C for 10 minutes. The spheroids were disaggregated
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to a single cell suspension by repeated pipetting and 
1.5ml of medium added to each well to neutralise the 
trypsin. 50/xl aliquots of this suspension were then 
added in triplicate to new 60mm Petri dishes each 
containing 4ml medium.
After incubation at 37°C for 7 days the cells were fixed 
and stained for 13-gal (section 2.4.4.4.) and the number 
of colonies > 50 cells counted. Those colonies staining 
positively for 13-gal were counted separately from the 
unstained colonies.
2.5.6 .2. Confirmation of heterogeneity within individual 
spheroids
Six day old spheroids initiated from a 1:5 ratio of CHO- 
Kl-BG to Adrr cells were picked off individually from a 
petri dish with a Pasteur pipette and each transferred to 
a single well of a 24 well microtitation dish. 0.5ml of 
0.25% trypsin solution was then added to each well and 
the dish was incubated at 37°C for 10 minutes. The 
spheroids were disaggregated to a single cell suspension 
by repeated pipetting and 1.5ml of medium added to each 
well to neutralise the trypsin. 200/xl from each well were 
then added to new 60mm Petri dishes each containing 4ml 
medium.
After incubation at 37°C for 7 days the dishes were fixed 
and stained for J3-gal and the number of marked and
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unstained colonies > 50 cells counted separately. The
proportion of positively staining colonies derived from 
individual mixed spheroids was therefore assessed.
2.5.6 .3. CHO spheroid coculture
Three sets of base coated flasks were seeded with 5 x 105 
cells. Two of the sets contained CHO-K1-BG or Adrr cells 
on their own, and the other contained a 1:5 mixture of 
CH0-K1-BG and Adrr . Following incubation of the flasks 
at 37°C for 5 days to allow spheroid initiation and 
growth, 1.25ml medium containing serial adriamycin 
dilutions was added to each flask, whilst 1.25 ml medium 
alone was added to control flasks. The flasks were 
incubated at 37°C for 24 hours and then medium and 
spheroids from each flask were transferred to 60mm Petri 
dishes. Under a dissecting microscope 10 spheroids of 
200-300nm diameter were selected from each dish by eye, 
picked off with a Pasteur pipette and transferred to one 
well of a 24 well microtitration dish.
0.5ml of 0.25% trypsin solution was then added to each 
well and the dish was incubated at 37°C for 10 minutes. 
The spheroids were disaggregated to a single cell 
suspension by repeated pipetting and 1.5ml of medium 
added to each well to neutralise the trypsin. 20/xl 
aliquots of this suspension were then added in triplicate 
to new 60mm petri dishes each containing 4ml medium and 
incubated at 37°C for 7 days. The dishes were then fixed
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and stained for 6-gal (section 2 .5.4.4.) and the number 
of colonies > 50 cells were counted and expressed as a 
percentage of control. In those dishes derived from 
mixed spheroids, the number of colonies staining 
positively for 6-gal were counted separately from the 
unstained colonies.
2.6. Microinjection of cells
2.6.1. Preparation of microelectrodes
Glass capillary tubes of 1.2mm outside diameter (Clark 
Electromedical Instruments) were pulled into 
microelectrodes and back filled with 5/xl of a 4% aqueous 
solution of Lucifer Yellow or 1% solution of adriamycin.
2.6.2. Injection procedure
Exponentially growing cells were trypsinised and 
resuspended in medium. 106 cells were seeded into 35mm 
Petri dishes each containing three 13mm diameter sterile 
glass coverslips in 2ml medium and incubated at 37°C for 
24 hours. For microinjection the coverslips were 
transferred to a 60mm Petri dish containing 3ml hepes 
buffered medium. The injection was monitored on a Leitz 
Orthoplan microscope with U.V. epi-illumination and 
visible (phase contrast) light sources. A suitable cell 
was selected and the electrode inserted using a 
micromanipulator. The cell was injected for one minute
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with hyperpolarising current pulses of 500ms duration , 
1Hz frequency and up to lOnA amplitude for Lucifer Yellow 
injections. A positive pressure injection system
(Picospritzer II, General Valve Corporation, USA) was 
employed for adriamycin injections. Dye spread to 
surrounding cells was monitored during and after 
injection and after 5 minutes the number of cells in 
which dye could be observed was recorded as an index of 
the extent of dye transfer.
2.7. Scrape loading
Exponentially growing BRL cells were trypsinised and 
resuspended in medium. 3 x 105 cells in 3ml medium were 
seeded into 60mm Petri dishes each containing six 13mm 
diameter sterile glass coverslips. After 24 hours 
incubation the coverslips were rinsed briefly in hepes 
buffered medium then transferred to dye-containing medium 
and immediately scored with a scalpel. After one minute 
the coverslip was removed from the dye-containing medium, 
washed twice in medium, twice in BSS/hepes and mounted 
cells downmost on a microscope slide for immediate 
examination. The dye concentrations used were: 1. 0.5%
lucifer yellow; 2. 0.5% lucifer yellow / 0.1% rhodamine
dextran; 3. 0.05% adriamycin.
74
Chapter 3 STUDY OF THE RELATIONSHIP BETWEEN
INTERCELLULAR COMMUNICATION AND DRUG RESISTANCE
3.1. Introduction
As discussed in chapter 1, there is evidence that the 
ability of cells to communicate through gap junctions is 
associated with resistance to radiation when cells are 
cultured in a three-dimensional arrangement in tumour 
spheroids or xenografts, and with resistance to TNF and 
lymphotoxin in monolayer culture. Studies with spheroids 
have also shown that three-dimensional culture confers a 
survival advantage following cytotoxic drug exposure, 
beyond that which might be explained by penetration 
limitations or cell kinetic factors. There have, 
however, been no reports investigating whether gap 
junctional communication might also contribute to this 
enhanced resistance.
This study was therefore designed to investigate whether 
the ability to communicate through gap junctions could be 
correlated with the extent of tumour cell resistance to 
conventional cytotoxic drugs. The tumour type selected 
for this purpose was human lung cancer.
For clinical purposes, human lung cancer is usually 
considered to consist of two major types: the first
comprising those tumours defined on morphological grounds 
as small cell lung cancer (SCLC) , and the second type,
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non- small cell lung cancer (NSCLC), which encompasses 
all other histological categories including squamous 
carcinoma, adenocarcinoma and large cell or anaplastic 
carcinoma. The relevance of this classification is shown 
in the distinct biological and clinical behaviour of the 
two types.
Although up to 80-90% of cases of SCLC are initially 
responsive to a number of cytotoxic drugs, including most 
of those included in the MDR group, acquired resistance 
develops in the majority of patients, either during the 
initial phase of chemotherapy or on relapse. Less than 
10% of patients with metastatic disease achieve long term 
disease-free survival and potential cure. In NSCLC in 
contrast most tumours are inherently drug resistant. The 
majority of cases are unresponsive to cytotoxic 
chemotherapy and those responses which are seen are 
usually partial and short-lived.
The cell lines used to study the relationship between 
intercellular communication and drug resistance were a 
panel of seven human NSCLC cell lines previously studied 
in the Department of Medical Oncology, University of 
Glasgow (see table 1 for list).
Earlier work with these cell lines (Merry et al. , 1987), 
none of which had been previously exposed to cytotoxic 
drugs in vitro, had shown this group of lines to exhibit 
cross resistance to members of the MDR group of drugs
76
including adriamycin, vincristine and etoposide. 
Assessment of the chemosensitivity of these cell lines 
was obtained using an assay based on measurement of cell 
viability by means of their ability to incorporate 3H- 
leucine into protein following drug exposure. Their 
results showed a considerable range in chemosensitivity 
observed between the different cell lines. This was 
particularly marked for adriamycin, where there was a 105 
fold difference in resistance between the most and least 
resistant lines (Table 2).
It was hypothesised that if cytotoxic drug resistance was 
related to the extent of gap junctional communication 
within a population, then in view of the magnitude of the 
chemosensitivity differences between the lines, 
correspondingly substantial differences in communication 
could be expected. It was proposed, therefore, to 
investigate the gap junction forming abilities of these 
cell lines to determine whether this also showed 
variation and if so, whether such variation might be 
related to their adriamycin resistance.
3.2. Assessment of cell-cell communication
3.2.1. Transfer of 3H uridine nucleotides
The extent of intercellular communication via gap 
junctions was assessed by a modification of the
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ID50(nM)
Adriamycin Vincristine Etoposide
A549 204-225 27-28 3600
Calu-3 2.7 1.6 23
L-DAN 34-70 17 920-1100
NCI-H23 0.002-0.005 1.9 330
NCI-H125 9.0 40 3810
SK-MES-1 48-53 13-22 810-1200
WIL 168 136 700-830
Table 2
NSCLC chemosensitivity: 3H leucine incorporation assay 
Adapted from Merry et al., 1987
nucleotide transfer technique originally described by 
Pitts and Simms (1977) (section 2.2.7.)* The principle 
underlying this technique is based upon uptake of H 
uridine by the growing donor cells and its conversion to 
labelled uridine nucleotides which are then incorporated 
into RNA. Washing with unlabelled medium removes the 
remaining free 3H uridine, leaving the labelled 
nucleotides and RNA. Coculturing donor and recipient 
cells allows the formation of junctions between the two 
groups of cells and the labelled uridine nucleotides are 
small enough to pass between donor and recipient cells in 
contact. The labelled nucleotides are then incorporated 
into the recipient cells' RNA and this incorporation can 
be assessed autoradiographically following TCA extraction 
to remove remaining nucleotides. If the cells form 
junctions, transfer of labelled material can be seen 
between donor and recipient cells in contact, whilst 
those recipient cells which are not in contact with the 
donor cell and have therefore been unable to form 
junctions remain unlabelled (fig.l).
3.2.2. Autoradiography
Autoradiographs for each experiment were developed 
following exposure times of 1-4 days. Thus for each 
experiment, a series of autoradiographic slides was 
obtained, each with a different combination of duration 
of coculture (1.5 or 3 hours) and of exposure. The
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Figure 1
Intercellular communication in NSCLC lines: transfer of
H uridine nucleotides between donor and recipient cells
105 cells/dish were seeded into each of two 35mm dishes, 
one with (recipient dish) and the other without (donor 
dish) 13mm coverslips . After 24 hours incubation the 
donor cells were labelled with 20/xCi H uridine for 2 
hours and then washed with medium, trypsinised and 
resuspended in 1ml medium. A 400/i 1 aliquot was then added 
to the recipient dish. After 3 hours incubation, the 
coverslips were washed in PBS, fixed in formol-saline, 
washed in ice-cold 5% TCA, H2O and ethanol and processed 
for autoradiography (section 2.2.6.). (a) A549; (b) L-
DAN; (c) Calu-3; (d) WIL.
(b) L-DAN
( c )  C a l u - 3
slides were examined microscopically to determine for 
each experiment which combination produced optimum 
autoradiographs for grain counting. The factors
influencing this selection were suitable cell density to 
allow identification of adequate numbers of donor- 
recipient pairs and of isolated cells on each coverslip; 
an appropiate grain count over recipient cells (a dense 
or confluent grain distribution would result in errors in 
grain counting using the image analysis system); and a 
background grain count as low as possible (see below).
Each autoradiographic slide was mounted with one 
coverslip from each of the cell lines used in the 
experiment so that when the optimum slide was selected 
for grain counting the exposure and coculture conditions 
were identical for each cell line. This allowed a valid 
comparison to be made between the junction forming 
abilities of the different cell lines.
For each cell line the number of grains over recipient 
cells in contact with donor cells (touching cells) could 
be compared to that over those clearly separated from 
donor cells (background cells). A small background grain 
count was always present and may result from a 
combination of the photographic background and medium 
mediated transfer of label. Increasing the number of 
washes, either with medium or TCA, employed in the 
experiment had no discernible effect on the background 
grain count.
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For each of the seven cell lines studied, some increase 
was observed in the grain counts over those recipient 
cells in contact with donor cells, in comparison to 
background cells. This was indicative of intercellular 
transfer of 3H uridine nucleotides from the donor cells, 
although the extent of transfer showed considerable 
variation between the cell lines (figs 1 and 2).
3.2.3. Quantification of gap junctional communication
In order to differentiate between those cell lines which 
form many junctions and are well coupled and those which 
form relatively few and are poorly coupled it was 
necessary to quantify the extent of intercellular 
transfer. Several indices were examined for this purpose 
including the ratio of mean grain count over touching 
cells to that over the background cells 
(touching/background ratio), and the mean touching cell 
grain count minus the mean background count.
Although the background grain count was usually of the 
order of only a few grains per cell, it was apparent that 
a small change in background, as a result of one of the 
factors discussed above, would have a disproportionately 
large influence on the touching/background (T/B) ratio. 
The results from a series of experiments with the A549 
cell line illustrate that such an index would result in 
an apparent six-fold difference in coupling ability of 
this cell line between different experiments (table 3).
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Figure 2
Intercellular communication in NSCLC lines: grain counts 
over recipient cells
Method as described for figure 1. For each cell line 
autoradiographic grains were counted over 30 recipient 
cells in contact with donor cells (touching cells) and 
over 30 recipient cells clearly separated from donor 
cells (background cells). For detail see section 2.2.7.
(a) A549; (b) Calu-3; (c) L-DAN; (d) NCI-H23; (e) NCI-
H125; (f) SK-MES-1; (g) WIL.
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mean grain 
count/cell
T B T/B T-B % coupling
Expt.
1 93 7 13.5 86 87
2 58 5 11.4 53 70
3 76 1.3 58.4 74.7 97
4 44 1 40.3 43 87
5 84 4 23.3 80 90
6 69 5 15.1 64 93
Table 3
Intercellular communication in A549: effect of different 
indices of coupling
H u n d i n e  nucleotide transfer performed as described in 
Figs.l and 2. Results of 6 separate experiments. Mean 
grain count/cell over touching (T) and background (B) 
cells. T/B represents ratio of mean grain count over T 
cells to that over B cells. T-B represents mean grain 
count over B cells subtracted from mean grain count over 
T cells. % coupling calculated as percentage of T cells 
where grain count was greater than mean +3 SD of 
background grain count.
Although the use of touching minus background (T-B) as an 
index reduces this variability, the differences in 
absolute grain count between experiments caused by 
variation in exposure duration also limit its usefulness.
To rank the cell lines with respect to their junction 
forming ability the variability in rate of junction 
formation was therefore utilised. Even in cell lines 
which exhibit extensive communication, over the time 
course of the experiment not every donor-recipient pair 
has formed sufficient gap junctions to show nucleotide 
transfer and the percentage of donor-recipient pairs 
which display coupling could therefore be used as an 
index of the strength of communication.
Coupling was defined as positive when the recipient cell 
had a grain count above that which could reasonably be 
attributed to "background factors". A cut-off grain 
count value of > mean + 3SD of the background grain count 
was employed. The use of this method avoided the 
problems associated with the other indices of coupling 
and removed much of the interexperimental variation 
caused by extraneous factors such as duration of exposure 
and variability in background grain count (see table 3).
In a series of experiments, a marked variation in 
junction forming ability between the different cell lines 
was observed (table 4). These experiments were performed 
sequentially over a period of 2-3 months. Not all cell
% coupling
Expt. 1 2 3 4 5 6 mean
A549 87 70 97 87 90 93 87
Calu-3 13 3 8
L-DAN 97 83 73 67 80 70 78
NCI-H23 57 67 57 43 67 58
NCI-H125 43 3 30 25
SK-MES-1 0 10 13 3 3 20 8
WIL 63 73 60 27 27 17 44.5
Table 4
Intercellular communication in NSCLC cell lines
3H uridine nucleotide transfer performed as described in 
Figs. 1 and 2. Results and mean of 6 separate 
experiments. In some experiments not all cell lines were 
included.
% coupling calculated as percentage of touching cells 
where grain count was greater than mean +3 SD of 
background grain count.
lines were available for initial experiments. One
feature of note is the apparent reduction in coupling 
ability of WIL over the time course of the study. No 
corresponding reduction was observed in the other cell 
lines and the observation may represent a genuine 
phenotypic change in WIL with continued culture, although 
this phenomenon was not explored further.
This index of coupling also had some limitations. 
Although the mean percentage coupling values of for 
example A549 at 87% and SK-MES-1 at 8% show that there is 
an 11 fold difference in frequency of coupling between
the two cell lines, they do not take account of the 
extent of communication between each donor-recipient 
pair, which is much greater for A549, as indicated by the 
considerably higher touching cell grain count observed in 
A549 compared to SK-MES-1 (see figs 2a and 2f) . This 
suggests that even the considerable differences in 
coupling frequency which have been obtained with this 
method may substantially underestimate the functional 
differences in extent of coupling between the cell lines.
Although the remaining interexperimental differences 
limited the precision of an exact ranking, several groups 
could clearly be distinguished. The cell lines could be 
divided into those with a very high frequency of
communication, L-DAN and A549; those with a very low 
frequency, SK-MES-1, Calu-3 and NCI-H125; and an
intermediate group, WIL and NCI-H23.
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Therefore in addition to the wide spectrum of adriamycin 
sensitivity previously reported by Merry and colleagues 
(table 2) , these cell lines also exhibited a marked 
difference in junction forming ability. However when 
these sets of data are compared no correlation between 
the two is observed (Spearman's rank correlation 
coefficient, rs= 0.51, p>0.05).
3.3. Cytotoxicity assays
3.3.1. Introduction
In order to validate the chemosensitivity data, and in 
view of the apparent instability of the WIL gap 
junctional communication phenotype observed above, it was
decided to perform further cytotoxicity assays to confirm
• .whether the values obtained from the H leucine
incorporation assay could be repeated in this laboratory 
using different assays of chemosensitivity.
Chemosensitivity of the cell lines was assessed by both 
clonogenic and MTT assays which have previously been 
shown to correlate well (Carmichael et al., 1987) . As
this study was concerned with the possible effects of 
intercellular communication within a coupled cell 
population on its response to cytotoxic agents, the 
methodological differences between clonogenic and MTT 
assays may be relevant.
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In a clonogenic assay the cells are necessarily separated 
and plated out at low density following the period of 
drug exposure, thus removing any effect of cell-cell 
contact from that time. In contrast, the MTT assay 
allows cells to continue to grow together following drug 
exposure before the enzymatic reduction of the 
tetrazolium salt MTT to a coloured formazan product is 
used as an index of cell number (Cole, 1986) . The 
extended period of culture in the MTT assay might 
therefore be expected to offer increased opportunity for 
and may maximise any effects of potential interactions.
3.3.2. Clonogenic and MTT assays: 24 hour drug exposure
For clonogenic assay, survival curves following 24 hour 
exposure to adriamycin show a marked similarity between 
the 7 cell lines (fig. 3). The mean IC50 of 2-3 separate 
experiments shows only a 3-fold variation between the 
least and most sensitive cell lines (table 5).
Survival curves derived from the MTT assay also show 
little difference between cell lines (fig.4) and produce 
a similar scatter of IC50 values (table 5). Although the 
ID50 values for the MTT assay are in general one order of 
magnitude greater than those obtained by clonogenic 
assay, this is largely a consequence of the very shallow 
dose-response curve seen with the MTT assay (Carmichael 
et al. , 1988a) , which also accounts for much of the
variability in IC50 between plates.
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Figure 3
NSCLC chemosensitivity: clonogenic assay
For each cell line 5 xlO3 cells/well in 100/xl medium were 
seeded into a 96 well plate, incubated overnight at 37°C, 
then the medium was replaced with fresh medium containing 
serial dilutions of adriamycin. After incubation for 24 
hours, the wells were washed twice with 100/ul medium and 
50/xl/well trypsin was added. After 10 minutes a further 
150/xl/well of medium was added and the cells were 
separated to a single cell suspension. 20/xl aliquots 
from each well were then added to 25cm2 flasks, incubated 
for 11-28 days and the resulting colonies were fixed in 
methanol and stained with 10% Giemsa. Colonies > 50
cells were counted and their survival expressed as a 
percentage relative to control wells without drug. Each 
point represents the mean of 2 experiments.
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Figure 4
NSCLC chemosensitivity: MTT assay
103 (A549, NCI-H23, L-DAN and WIL), 2.5 x 103 (NCI-H125)
or 5 x 103 (Calu-3) cells/well in 200/xl medium were 
seeded into 96 well plates and incubated at 37°C for 3 
days. The medium was then replaced with fresh medium 
containing serial adriamycin dilutions and reincubated 
for a further 24 hours. The medium and drug were removed 
and replaced with fresh medium then and on each of the 
next two days. On the fourth day following drug exposure 
the medium was replenished with the addition of lOmmol 
hepes buffer. 50/il/well of 4.5mg/ml MTT was then added 
and the plates were reincubated in darkness for a further 
4 hours. The medium was then removed and the MTT 
formazan crystals dissolved in 200|il DMSO. 25/xl of 0.1M 
tris buffer was added to each well and the plates were 
read on an ELISA plate reader at an absorbance of 570nm 
and their absorbance calculated as a percentage relative 
to control wells without drug. Each point represents the 
mean of 8 wells.
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IC50(nM)
Clonogenic assay MTT assay
A549 7.7 (1.4) 207
Calu-3 8.7 (3.3) 138
L-DAN 14.7 (1.9) 129
NCI-H23 13.5 (1.0) 94
NCI-H125 21.5 (5.3) 50
SK-MES-1 8.0 (1.4) 66
WIL 19.0 (2.1) 74
Table 5
NSCLC chemosensitivity: comparison of clonogenic and MTT 
assays
Assays performed as described in Figs. 3 and 4. IC50 
determined graphically as drug concentration which 
reduced survival of colonies (clonogenic assay) or 
absorbance (MTT assay) to 50% of that obtained from 
controls in the absence of drug. Values for clonogenic 
assay represent mean (+SD) of 2-3 separate experiments.
The narrow range of IC50 values from either assay, and 
the consequent discrepancy between the two methods in 
ranking of chemosensitivity based on these values 
(Spearman's rank correlation coefficient, rs= -0.607, 
p>0.05), suggests that they are unlikely to represent 
important differences in chemosensitivity between the 
seven cell lines.
3.3.3. Clonogenic assay: 72 hour drug exposure
The reason for the discrepancy between chemosensitivity 
results obtained in this study and the broad spectrum of 
chemosensitivity previously reported for these lines by 
Merry et al. (1987) is not clear. In the 3H leucine
incorporation assay of the earlier report the period of 
drug exposure employed was 72 hours, and it was possible 
that longer periods of drug exposure might reveal 
chemosensitivity differences not apparent following 24 
hour drug exposure used in the MTT and clonogenic assays 
described here.
To investigate this possibility, the most sensitive cell 
line on the basis of 3H leucine incorporation, NCI-H23, 
and the least sensitive line, A549, were studied further. 
If duration of drug exposure was critical, changes in 
chemosensitivity resulting from variation in exposure 
time should be most readily apparent in those lines at 
opposite ends of the chemosensitivity range.
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A clonogenic assay was therefore performed for each of 
these two cell lines using a 72 hour period of adriamycin 
exposure. In comparison to the 24 hour exposure, this 
resulted in a shift of the survival curves of both cell 
lines to the left (fig.5). This reduced the IC50 for 
NCI-H23 from 13.5 to 2.8nM and that for A549 from 7.7 to 
5.5nM. Therefore, although increasing the duration of 
adriamycin exposure does appear to have a more marked 
effect on NCI-H23 than on A549, it does not seem likely 
to significantly affect the range of chemosensitivity 
seen with these lines. The discrepancy between
chemosensitivity results obtained with 3H leucine and 
clonogenic assays can not therefore be explained on the 
basis of differences in duration of drug exposure.
3.3.4. Spheroid clonogenic assay
In view of the lack of association between gap junctional 
communication and chemosensitivity of these cell lines, 
it was decided to investigate whether, as with radiation 
response, 3-dimensional contact was a necessary condition 
for any protective effect of intercellular communication 
on the cell lines to be manifest.
Two of the cell lines, L-DAN and SK-MES-1, were therefore 
cultured as multicellular spheroids and a clonogenic 
assay performed on the spheroid cells by spheroid 
disaggregation following drug exposure. These two cell 
lines were selected as representing lines of widely
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Figure 5
NSCLC chemosensitivity: clonogenic assay, comparison of
24 and 72 hour drug exposure
24 hour drug exposure was performed as described in Fig 
3. The method of 72 hour drug exposure was identical with 
the exceptions that NCI-H23 were seeded at 2 x 10 
cells/well and L-DAN at 10 cells/well. Triplicate wells 
were prepared at each drug concentration and medium and 
drug were replenished at 24 and 48 hours.
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differing junction forming ability, and might therefore 
be expected to confirm whether junctional communication 
was associated with increased spheroid resistance to 
adriamycin.
Survival curves derived from a series of three 
experiments were very similar for each cell line (fig.6) 
and produced IC50 values of 131 nM for L-DAN and 80nM for 
SK-MES-1.
Thus, for both cell lines, culture as three-dimensional 
spheroids produces a 9-fold increase in adriamycin 
resistance over monolayer (compare table 5) . This equal 
advantage for two cell lines of widely differing 
communication ability again supports the absence of a 
role for intercellular communication in adriamycin 
resistance in this model.
3.4. Discussion
3.4.1. Introduction
This study confirms the wide variation in gap junction 
forming ability which has been reported to exist between 
different tumour cell lines (Morgan et al. . 1982, Miller
et al. . 1983) and demonstrates that the nucleotide
transfer technique is able to reproducibly quantify the 
extent of coupling. If junctional communication plays a 
significant role in determining the cellular response to
87
Figure 6
NSCLC chemosensitivity: spheroid clonogenic assay
1.25ml medium containing serial adriamycin dilutions was 
added to 25cm2 BCF containing 5ml medium and 5-6 day old 
L-DAN or 6-8 day old SK-MES-1 spheroids. After 24 hours 
incubation at 37°C, 10 spheroids from each dish were
transferred to one well of a 24 well microtitration dish. 
0.5ml of 0.25% trypsin solution was added to each well, 
the spheroids were disaggregated to a single cell 
suspension by repeated pipetting and 1.5ml of medium 
added to each well. 200/il aliquots of this suspension 
were then added in triplicate to new 25cm2 flasks and 
incubated at 37°C. The resulting colonies were fixed in 
methanol and stained with Giemsa. Colonies > 50 cells 
were counted and their survival expressed as a percentage 
relative to control flasks without drug. Each point 
represents the mean (+/-SEM) of 3 separate experiments. 
Drug concentrations are calculated assuming even 
distribution of adriamycin between medium and agar.
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cytotoxic drug treatment then this panel of seven human 
NSCLC cell lines would have been ideally suited to 
demonstrate a relationship between junctional 
communication and adriamycin sensitivity.
3.4.2. Cytotoxicity assays
The narrow range of chemosensitivity of the seven cell 
lines as assessed both by clonogenic and MTT assays was 
therefore surprising, particularly in view of the 
previously reported large variation in adriamycin 
sensitivity as measured by 3H leucine incorporation assay 
(Merry et al. . 1987), although that data is based upon
only the results of one or two experiments per cell line.
The results from 72 hour drug exposure in this study 
suggest that the difference in duration of drug exposure 
is not a sufficient explanation for this discrepancy. 
Subsequent clonogenic assay and MTT studies from that 
laboratory with these lines (R.I. Freshney, personal 
communication) have also failed to find a significant 
range of chemosensitivity and thus support the present 
findings.
Carmichael et al. (1988a) studied a large number of SCLC
and NSCLC lines including three of those in this study 
(NCI-H23, NCI-H25 and A549) and similarly found little 
difference in their chemosensitivities as measured by MTT
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assay, parallelling the consistently adriamycin resistant 
behaviour of these tumours in the clinical setting.
3.4.3. Role of spheroid geometry
Culture of cell lines as multicellular spheroids 
increases the resistance of both well-coupled and poorly- 
coupled cells to an equal extent, therefore in this 
system at least, there is no evidence to implicate 
junctional communication in spheroid resistance. The 
contribution of penetration and kinetic influences to 
this increased spheroid resistance was not examined in 
this study although penetration barriers to adriamycin 
have previously been reported to be present in L-DAN 
spheroids and to contribute to their drug resistance by 
Kerr and colleagues (1986), although in their study the 
duration of adriamycin exposure was only one hour and it 
is possible that the 24 hour exposure in the current 
study allows sufficient time to overcome such a barrier.
Therefore, this study using human tumour lines is in 
agreement with previous reports in rodent lines of 
increased adriamycin resistance of spheroids over 
monolayer (Sutherland et al.. 1979; Durand, 1981).
Among the mechanisms of spheroid resistance proposed by 
those earlier studies was that sharing of some 
intermediary metabolites or messengers between cells in a 
three dimensional structure might confer increased
resistance on the population in a manner analgous to the 
metabolic cooperation originally described by Subak-
Sharpe et al. in 1966. Cell to cell transfer of 
glutathione (GSH) would be one plausible explanation.
This model is dependent on communication between the 
cells and based upon the assumption that such
communication might be more extensive in three
dimensional spheroid culture. The reports of Dertinger, 
Hinz and Jacobs (1982) and Sutherland (1986) of reduced
rather than increased coupling when cells are cultured as 
spheroids seems to contradict this explanation and the 
failure of junctional communication to influence spheroid 
adriamycin resistance in this study also suggests that 
some further mechanism may be involved.
3.4.4. Relevance of cytotoxicity assay techniques
It is possible that the assay methods employed in this 
study have disadvantages which limit their suitability in 
a study of communication related phenomena. If sharing 
of GSH or some intermediary metabolite has a role to play 
in drug resistance, the timing and duration of cell 
coupling may be critical. Maintainance of communication 
in the cell population in the period following drug 
exposure, in addition to communication during the 
exposure period itself, may be necessary to enable 
limitation of or recovery from drug induced damage.
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In clonogenic assays involving both monolayer and 
spheroid systems in this study, the cells are trypsinised 
and separated immediately following drug exposure and 
plated out at low density, eliminating any junction 
mediated metabolic cooperation from that time. The 
ability of the individual cell to survive the period of 
drug exposure and retain its clonogenic potential is the 
only property which this assay can detect. For 
junctional communication to influence this property, it 
would be essential that communication during drug 
exposure itself was sufficient to limit drug induced 
damage.
The introduction of the MTT assay was designed to 
overcome these reservations regarding clonogenic assays. 
In the MTT assay cells are allowed a 72 hour period in 
undisturbed culture to recover from drug exposure and to 
continue to divide before the reduction of MTT is used as 
an index of cell number, and, by inference, of the 
surviving fraction of clonogenic cells. However,
although the MTT assay avoids the disruption of 
junctional contact inherent in clonogenic assays it too 
has its limitations. In order to allow the surviving 
cells to continue in exponential growth for 72 hours 
following drug exposure, it is implicit that at the time 
of drug exposure itself, they were subconfluent. 
Therefore although the MTT assay allows maintainance of 
intercellular communication following drug exposure, this 
is at the expense of reduced communication during the
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early stages of the assay as a result of lower cell 
density.
Neither assay is therefore capable of allowing optimum 
communication both during and following drug exposure. 
As the proposed protective mechanism of intercellular 
communication is itself unclear, the relevance of these 
methodological differences between the two assays of
chemosensitivity is uncertain, but in conjunction the
assays allow assessment of the effects of gap junctional 
communication at most times of potential importance and 
might be considered complementary.
An alternative assay method which was not investigated in 
this study, but which might circumvent these problems, is 
one based on measurement of spheroid growth delay 
following drug exposure, where the duration of drug 
induced delay in spheroid growth relative to untreated 
control spheroids is used as an index of 
chemosensitivity. In this system, as in tumours in
vivo, cell-cell contact is present before, during and
after drug exposure, affording optimum opportunity for 
metabolic cooperation to influence response.
The evidence from this present study suggests that the 
previously demonstrated relationship between junctional 
communication and resistance to radiation or to the 
cytotoxic lymphokines TNF and lymphotoxin may not
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represent a generalised phenomenon, applicable to all 
conventional cytotoxic drugs.
3.4.5. Potential role for GSH in determining cytotoxicity
The mechanism whereby TNF and lymphotoxin exert their 
cytotoxic effect remains uncertain although there is 
evidence that free radical induced DNA fragmentation may 
be involved (Matthews et al. . 1987, Rubin et al. . 1988
and Yamauchi et al. . 1989) . It is possible that this
common pathway of radiation or lymphokine damage is 
responsible for the reported association between 
resistance to these treatment modalities and junctional 
communication. The role of intercellular GSH transfer in 
modulation of cytotoxicity in such coupled populations 
would be of interest.
Carmichael et al. (1988b) measured GSH levels in a large 
series of human small and non-small cell lung cancer 
lines. As a group, the NSCLC lines had significantly
higher GSH levels than the SCLC lines which may be 
relevant to their differences in drug sensitivity in the 
clinical setting. Included in their NSCLC group were 
three of the lines in this study, NCI-H23, NCI-H125 and 
A549, and no significant difference in GSH levels was
observed between the three. No information is available 
regarding GSH levels in the other lines used in the
present study.
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Although intracellular GSH levels may have a role in 
limiting adriamycin toxicity in some resistant cell lines 
(Dusre et al. . 1989), the importance of this agent in 
determining the drug response of these NSCLC cell lines 
is unknown.
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Chapter 4 STUDY OF THE INTERACTION OF SENSITIVE AND 
RESISTANT CELLS IN MIXED CULTURE
4.1. Introduction
The original intention of this project was to employ the 
human NSCLC cell lines studied in Chapter 3 to 
investigate whether growth of sensitive and resistant 
cell lines in mixed culture resulted in interaction 
between the cell lines leading to modulation of their 
drug response. The wide spectrum of chemosensitivity of 
these cell lines reported by Merry et al. (1987) was 
considered appropriate to allow selection of a relatively 
resistant and a relatively sensitive pair of lines 
suitable for combining in mixed culture.
The presence of a pattern of cross resistance to 
adriamycin, vincristine and etoposide in these cell lines 
suggested that their drug resistance might result from 
increased mdrl expression. This was supported by the 
ability of the calcium antagonist verapamil to reduce 
drug accumulation and increase sensitivity in some of the 
lines (Merry et al., 1987). Therefore as proposed by the 
model in section 1.7.4. intercellular drug transfer 
between adjacent sensitive and resistant cells in mixed 
culture might alter their drug response.
The subsequent contradiction of this chemosensitivity 
data, at least for adriamycin, by MTT and clonogenic
assays (Chapter 3) rendered these lines clearly 
unsuitable for use as "sensitive” and "resistant" lines 
in mixed culture. It was therefore necessary to examine 
alternative cell lines.
4.2. Studies with sensitive and resistant murine 
astrocytoma cell lines
4.2.1. Introduction
In view of the unsuitability of the NSCLC lines for mixed 
culture experiments, it was decided to examine a pair of 
sensitive and resistant lines where some interaction had 
already been suggested in mixed culture.
Bradford et al. (1986) had presented a preliminary report 
on their studies with clonal cell lines derived from the 
P497 cell line, originally isolated from a spontaneous 
murine astrocytoma.
Characterisation of the chemosensitivity of these cell 
lines had shown that two of the lines, C12 and FI, had 
shown wide differences in sensitivity to the vinca 
alkaloids vincristine and vindesine, as measured by 35S 
methionine uptake assay. There was no difference in 
adriamycin sensitivity between the two lines (table 6) . 
Mixed monolayer culture of the two cell lines had shown 
that the combination adopted the chemosensitivity of the 
more resistant line (C12), suggesting possible transfer
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Mean IC50 (mg/ml) ± S.E. 
C12 FI
vincristine 
vindesine 
adriamycin
61 ± 2 
85 ± 1 
230 ± 10
5 ± 0 
4.2 ± 
190 ±
Table 6
Chemosensitivity of murine astrocytoma lines: 
S methionine uptake assay
(J. Darling, unpublished data)
.8
0.3
10
of resistance although the individual response of the two 
cell lines in mixed culture was not examined.
These two cell lines were obtained from Dr. J.L. Darling 
(London) and it was proposed to perform further mixed 
culture studies with the lines after genetic marking with 
6-galactosidase (B-gal) to determine whether this 
reported interaction could be confirmed, and if so to 
relate this to alterations in the individual 
chemosensitivity of the two lines.
4.2.2. Genetic marking with B-galactosidase
Retroviral mediated gene transfer using the ecotropic 
virus producer line G4-12.2-Y7 ( Price, Turner and Cepko, 
1987) was performed (section 2.4.2.). A high proportion 
of cells survived G418 selection and within two weeks 
there were adequate cell numbers for B-gal histochemical 
staining. This was positive for both cell lines. FI 
showed approximately 90% positive staining, whereas C12 
showed approximately 60% staining.
4.2.3. Assessment of chemosensitivity
Concurrently with the above retroviral infection 
procedures, a clonogenic assay was performed on the two 
cell lines in order to confirm that the chemosensitivity 
differences reported with the 35S radiolabelled
methionine uptake assay were maintained in the assay 
system necessary for coculture studies.
The survival curves from the first pair of assays using 
an initial cell density of 105 cells/well (figs 7a and 
7b) , whilst showing some reduction colony survival 
following drug exposure, have a quite different 
appearance from those obtained with NSCLC cell lines (see 
fig.3). The most striking feature of the survival curves 
is that at higher drug concentrations there is no further 
reduction in colony survival. It is therefore impossible 
to accurately calculate the IC50 value for either cell 
line.
It was considered that the most probable explanation for 
the appearances of these survival curves is the mechanism 
of action of the two drugs. The cytotoxicity of vinca 
alkaloids results from their interference with the 
formation of the mitotic spindle and they therefore only 
act on cells during division. Although the 24 hour 
duration of drug exposure employed in the assay should 
allow all cycling cells to undergo mitosis during this 
period, it is probable that the number of cells present 
per well resulted in density limitation of cell growth, 
particularly at the edges of wells where cells were most 
confluent on microscopical examination. As a result, a 
proportion of cells in each well were no longer dividing 
and were therefore resistant to the drugs, even at high 
concentration.
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Figure 7
Chemosensitivity of murine astrocytoma lines: clonogenic
assay
105 cells/well were added to a 24 well plate. After 24 
hours incubation at 37°C, the medium was removed and 
replaced with fresh medium containing serial dilutions of 
vindesine (a) or vincristine (b) . One set of wells 
contained medium alone and acted as control. Following a 
further 24 hours incubation, the medium and drug were 
removed and 200/il 0.25% trypsin solution was added to
each well. After 10 minutes incubation 1.8ml/well of 
medium was added and the cells separated to a single cell 
suspension by repeated pipetting, then counted on a 
Coulter counter and 5 x 102 cells/well were plated into 
triplicate 60mm petri dishes, incubated for 8 days, fixed 
in methanol then stained with 10% Giemsa. Colonies > 50 
cells were counted and their survival expressed as a 
percentage relative to control wells without drug.
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Although the separation of the two survival curves 
suggests some difference in chemosensitivity, this is not 
marked. In the survival curves following vindesine 
exposure (fig.7a) in particular there is a striking 
similarity between the shapes of the two curves. As each 
point on the curve is calculated relative to the control 
survival in the absence of drug it is clear that the low 
survival of the control C12 colonies is the only 
difference between the two curves. If, as might be
expected, the control survival had been approximately 
equivalent to that of the lowest drug concentration then 
the two survival curves would have been almost exactly 
superimposed.
The survival curves following vincristine exposure 
(fig.7b) appear more clearly separated, perhaps
indicative of a genuine difference in chemosensitivity,
although it is possible that the faster growth rate of 
C12 cells allowed them to reach confluence earlier, thus 
accounting for their apparent increase in resistance.
A second pair of assays was therefore performed at a 
lower initial cell density of 2xl04 cells/well to examine 
whether this would remove the complicating factor of cell 
confluence during drug exposure and enable any true
chemosensitivity differences to be evident.
The survival curves from these assays (figs 8a and 8b) 
confirm the reduced survival with increasing drug
concentration which would be expected in the absence of 
density limitation of growth. It is also clear, however, 
that with either drug the survival curves of C12 and FI 
are closely superimposed suggesting that by clonogenic 
assay there is no significant difference in vinca 
alkaloid chemosensitivity.
On the basis of these assays, the IC50 value of both cell 
lines to vindesine is approximately 0.025/xg/ml and to 
vincristine is 0.018/ig/ml, both of which are intermediate 
between the values reported for the two lines by 35S 
methionine incorporation. The explanation for the 
discrepancy between clonogenic and 35S methionine 
incorporation assays is unclear. Previous studies 
(Morgan et al.. 1983) suggest good correlation between
the two assays. The influence of cell density on IC50 
values may be partially responsible.
In the absence of a significant chemosensitivity 
difference by clonogenic assay, there was no value in 
proceeding with the proposed mixed culture experiments. 
Therefore neither the parent nor 6-gal marked lines were 
studied further.
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Figure 8
Effect of reduction in cell density on chemosensitivity 
of murine astrocytoma lines
Method as described in figure 7 except that initial cell 
density was 2 x 104 cells/well. Colonies > 50 cells were 
counted and their survival expressed as a percentage 
relative to control wells without drug.
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4.3. Studies with sensitive and resistant Chinese 
hamster ovary (CHO) cell lines
4.3.1. Introduction
As the murine lines, C^2 anc* Fi were unsuitable for mixed 
culture studies, an alternative model system was 
therefore sought. A group of Chinese hamster ovary (CHO) 
cell lines of varying chemosensitivity was obtained from 
Dr I Hickson, University of Newcastle on Tyne. These 
comprised the parental line, CH0-K1, a multidrug 
resistant cell line, Adrr and a drug-hypersensitive cell 
line, ADR-6 .
Adrr was derived from the parental line by culture in 
adriamycin and exhibits cross resistance to colchicine, 
mitozantrone, mitomycin C, vicristine and actinomycin D. 
Amplification of mdrl sequences together with increased 
mdrl mRNA expression and P-glycoprotein have been 
demonstrated in this line compared to CH0-K1 (Chatterjee 
and Harris, 1990; I. Hickson, personal communication). 
The hypersensitive mutant ADR-6 was selected following 
exposure of the parent line to the mitogen ethyl 
methanesulphonate, and has therefore never been exposed 
to adriamycin. It is also cross-sensitive to vincristine 
and colchicine (I.Hickson, personal communication).
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4.3.2. Confirmation of chemosensitivity
Adriamycin chemosensitivity of CH0-K1, ADR-6 and Adrr was 
assessed by clonogenic assay. The survival curves 
generated from this experiment (fig. 9) show clear 
differences in drug sensitivity between the different 
cell lines. The resultant IC5Q values were CH0-K1 
64nmol, ADR-6 16.6nmol and Adrr 2390nmol. Thus the MDR 
cell line Adrr was 37-fold more resistant to adriamycin 
than the parental line, whilst the hypersensitive line 
ADR-6 was almost 4-fold less resistant. These results 
are in close agreement with the sensitivities reported by 
the Newcastle group (Chatterjee and Harris, 1990; I. 
Hickson, personal communication).
4.3.3. Coculture of sensitive and resistant cells:
> . . *1 . . .  .preliminary studies of H thymidine incorporation
4.3.3.1. Introduction
This initial study employed an assay technique where the 
cells' ability to incorporate 3H thymidine into newly 
synthesised DNA during the S phase of the cell cycle is 
used as a marker of continued cell division and therefore 
of survival following drug exposure. Measurement of the 
total incorporation of label by scintillation counting at 
a specified time following drug exposure is thus an index 
both of cell number and reproductive capacity and
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Figure 9
CHO chemosensitivity: clonogenic assay
5 x 103 cells in 100/ul medium were seeded into each well 
of a 96 well plate, incubated overnight at 37°C, then the 
medium was removed and replaced with fresh medium 
containing serial adriamycin dilutions. After 24 hours 
incubation the medium and drug were removed and 50/xl/well 
of trypsin added. 150ul medium was then added and the 
cells were separated to a single cell suspension. 20/xl 
aliquots from each well were then added to 25cm2 flasks, 
incubated for 7 days at 37°C, fixed in methanol and 
stained with Giemsa. Colonies > 50 cells were counted 
and their survival expressed as a percentage relative to 
control wells without drug.
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therefore, as with the MTT assay (section 2.3.2.), is an 
indirect measure of the survival of clonogenic cells.
In addition to scintillation counting, the cells were 
processed for autoradiography. The actively cycling cells 
could be identified by the presence of autoradiographic 
grains visible overlying their nuclei, indicative of 
incorporation of label into their DNA. This allowed some 
indication of the survival of individual cells, rather 
than of the entire population, and it was hoped that this 
would prove useful in studying the individual response of 
the two cell types in mixed culture.
Based on the doubling time of the cell lines (section 
4.3.4.5.), a 24 hour period of labelling was chosen so 
that all cycling cells would be likely to pass through 
the S phase of the cell cycle during this period and thus 
incorporate the label.
The initial experiment was designed to determine the 
optimum timing of labelling in relation to drug exposure, 
in order to maximallly differentiate between the response 
of the two cell lines studied, the parent (sensitive) 
line CH0-K1, and the resistant line Adrr . Three 
labelling periods were studied: day 1, i.e. concurrent
with drug exposure, day 2 or day 4 of the assay.
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4.3.3.2. Scintillation counting
Survival curves were generated by plotting of total 
scintillation counts (relative to those of control dishes 
without drug) versus drug concentration. It was possible 
to compare the survival curves of CH0-K1 cells alone, 
Adrr cells alone and of a 50:50 mixed culture of the two 
cell types for each of the chosen labelling periods.
Labelling of cells on day 1 showed no differences between 
the three groups of cells. It was likely that 
insufficient time had elapsed for the full cytotoxic 
effects of the drug to occur and allow any differences in 
drug responses of the lines to be evident. However, 
labelling on day 2 (fig. 10a) and day 4 (fig. 10b) showed a 
clear distinction between the curves of CHO-K1 and Adrr . 
In the day 4 label, the survival of the mixed culture was 
intermediate between that of the two cell types cultured 
separately, whilst in the day 2 label, the survival of 
the mixed culture appeared even higher than that of Adrr 
alone.
4.3.3.3. Autoradiography and labelling index
Calculation of the labelling index (LI) from coverslips 
submitted for autoradiography also confirmed a marked 
difference between CHO-K1 and Adrr , particularly when 
labelled on day 4. At this point the LI of Adrr 
following exposure to the highest drug concentration was
104
Figure 10
Coculture of CHO-K1 and Adrr : 3H thymidine incorporation 
assay
(al day 2 labelling
105 cells (CHO-K1 alone, Adrr alone or a 50:50 mixture of 
the two cell types (mixed)) in 2ml medium were seeded 
into 35mm dishes, each containing 3 x 13mm coverslips. 
Following 2 hours incubation at 37°C, 1ml medium 
containing serial dilutions of adriamycin at 3 times the 
final concentration was added. After a further 24 hours 
incubation the drug and medium were removed and replaced 
with fresh medium and 3H thymidine (200/iCi/ml in PBS, 
50/xl/dish) was added. After 24 hours incubation, the 
dishes were washed in PBS, fixed in formol-saline and the 
coverslips washed in ice-cold 5% TCA, H2O and rinsed in 
ethanol. The coverslips were then added individually to 
scintillation vials and counted for one minute on a 
scintillation counter.
(b) day 4 labelling.
Method as above except that after the period of drug 
exposure, medium and drug were removed and replaced with 
fresh medium alone and dishes reincubated at 37°C for a 
further 48 hours before addition of H thymidine. The 
counts for each coverslip are expressed as a percentage 
relative to control dishes without drug.
FI
GU
RE
 
10
a
co
cu
ltu
re
 
of 
C
H
O
-K
1 
an
d 
A
dr
r 
3H 
th
ym
id
in
e 
in
co
rp
or
at
io
n 
as
sa
y
U>
<D
-Q
CM
>*
(O
■ O
o
o  
_ o  
- o
o
o
_ o
o o
CM
o
o
o
00
o
CO
o o
CM
(%) inuj/sjunoo
ad
ria
m
yc
in
 
(n
M
)
FI
GU
RE
 
10
b
co
cu
ltu
re
 
of 
C
H
O
-K
1 
an
d 
A
dr
r 
3H 
th
ym
id
in
e 
in
co
rp
or
at
io
n 
as
sa
y 
da
y 
4 
la
be
lli
ng
o
" O
X  T3 
O  <
O  
_ o  
- o
o
_ o
o oo o o o o
CM o  ao CO CM
(%) ujuu/siunoo
ad
ria
m
yc
in
 
(n
M
)
89% whilst for CH0-K1 it was only 12%. The LI of the 
mixed culture at this adriamycin concentration was 90% 
and therefore comparable to that of Adrr alone. Although 
this result was consistent with resistance transfer, the 
finding was not confirmed in subsequent experiments. 
Other considerations discussed below suggest that this 
result may be spurious.
At the higher drug concentrations where the difference 
between the sensitive and resistant lines was most 
apparent it was difficult to identify intact cells in 
view of considerable cell disruption and debris, and this 
limited the accuracy of counting. It was clear that in 
coverslips with CH0-K1 cells alone, the drug toxicity was 
more severe and cells were more sparse with frequent 
abnormal forms. Thus, although viable labelled cells 
could be clearly distinguished, the accuracy of the 
denominator used for calculation of the LI, i.e. the 
total number of cells present, was uncertain. The 
potential error was considered to be sufficiently large 
to negate the value of the LI in this study and it was 
not examined further. In a series of subsequent 
experiments (section 4.3.3.4.), therefore, scintillation 
counting alone was studied.
4.3.3.4. Scintillation counting: effect of cell density
In selecting the optimum experimental conditions for 
these subsequent studies, it was important to allow a
sufficient period of time to elapse between drug exposure 
and labelling for adequate distinction between the 
responses of Adrr and CH0-K1. However it was necessary 
to balance the duration of the experiment with the 
initial density of cells seeded into the dishes. As 
previously discussed with regard to the MTT assay, in 
order to allow for continued growth of cells for several 
days following drug exposure, the cells must initially be 
subconfluent, thus limiting the potential for 
intercellular communication. A long delay before
labelling in an attempt to maximise the differential drug 
responses would inevitably require a correspondingly low 
initial cell density.
Based on the results of these preliminary experiments 
further studies were therefore performed with 3H 
thymidine labelling on day 3. The effect of different 
initial densities of 1 x 105 cells/dish and 5 x 105 
cells/dish was also studied. The resulting survival 
curves (figs 11a and lib) again showed a clear separation 
between the survival curves of Adrr and CH0-K1, although 
on each occasion the curve for the 50:50 mixture lay mid­
way between those of the pure cultures i.e. in the 
position which would have been predicted from the curves 
of Adrr and CH0-K1 alone, assuming no interaction.
These survival curves are generated using the mean 
scintillation counts of two separate coverslips. 
Although it was attempted to exclude coverslips with a
Figure 11
Coculture of CH0-K1 and Adrr : H thymidine incorporation
assay, day 3 labelling
Method as described in Fig.10a except that initial cell 
density was 105 cells/dish (a) or 5 x 10 cells/dish (b) . 
After the period of drug exposure, medium and drug were 
removed and replaced with fresh medium alone and dishes 
reincubated at 37°C for a further 24 hours before 
addition of 3H thymidine. The counts for each coverslip 
are expressed as a percentage relative to control dishes 
without drug.
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clearly non-uniform distribution of cells for 
scintillation counting, some inhomogeneity remained, and 
therefore limited the accuracy of the survival curves. 
To exclude the possibility that such inhomogeneity might 
mask a significant interaction between the two cell 
types, a further study was performed to compare the 
results obtained counting intact coverslips as above, 
with those where the cells were seeded into dishes 
without coverslips, and the incorporation of label 
measured following solubilisation of all cells in the 
dish (see section 2 .5.3.2 .).
The resulting survival curves (figs 12a and 12b) showed 
essentially identical results with or without coverslips, 
suggesting that any inhomogeneity in cell distribution 
had no substantial effect on these results. To maximise 
potential interactions a high initial cell density was
• • • fi •used in this experiment (1 x 10 cells/dish) and
labelling was performed on day 2 , before cell division
was limited by confluence.
With the exception of one experiment from the preliminary 
study (fig 10a) these results have therefore consistently
O . . . ' •
shown that JH-thymidine incorporation, and effectively 
the survival, of the 50:50 mixture of Adrr and CHO-K1 to 
have a value intermediate between that of either cell
type cultured alone. This result is that which would
have been calculated for such a mixed culture, from the 
data from the separate cultures, assuming both cell types
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Figure 12
Coculture of CH0-K1 and Adrr : 3H thymidine incorporation
assay, day 2 labelling
(a) method as described in Fig.10a except that initial 
cell density was 10 cells/dish. (b) method as described 
in Fig.10a except that dishes did not contain coverslips, 
initial cell density was 10 cells/dish and the activity 
of the label was 40juCi/ml. Following TCA extraction, the 
cells were solubilised in 2ml 0.1M NaOH, then acidified 
with 0.3ml 1M HC1 and added to scintillation vials for 
counting. The counts for each dish or coverslip are 
expressed as a percentage relative to control dishes 
without drug.
FI
GU
RE
 
12
a
co
cu
ltu
re
 
of
 
C
H
O
-K
1 
an
d 
A
dr
r  
3H 
th
ym
id
in
e 
in
co
rp
or
at
io
n 
as
sa
y 
da
y 
3 
la
be
lli
ng
, 
wi
th
 
co
ve
rs
lip
s
in
"O
o
o
o
r O
_ O
o o o o o o o o
^  CM O  00 CO CM
(%) ujiu/siunoo
ad
ria
m
yc
in
 
(n
M
)
IA
JQ
CVJ
LU
OC
3
(3
>*
(G
(/)
TJ CO
< ra
TO c
C o
(0 ’+-»
(0T“ La
o
| Q.1
O
i_
o
X o
o c
H— <Do _c
0) TO
V.
=3 E
>*
=3 _c *—*
O
o Xo n
CO
Q.
w
k_
a>
>
o
o
_Q
J5
00
>s
(0
"O
X  -O
o
oo
o
o
r O
o oo o o oo
CVJ GO CO C\J
(%) muj/siunoo
ad
ria
m
yc
in
 
(n
M
)
continued to respond individually, and would therefore be 
consistent with an absence of interaction between the two 
populations under these conditions.
Although this study would exclude transfer of drug 
resistance of the magnitude suggested by the work of 
Tofilon et al. (1987) and Bradford et al. (1986) , where 
the overall response of the mixed population showed a 
shift towards that of the resistant line, the possibility 
of some interaction remains.
This study only provides information on the overall 
response of the mixed population and it is possible that 
some interaction is occurring which has the effect of 
reducing the resistance of Adrr and increasing that of 
CH0-K1, thus producing an intermediate but uniform 
response in the mixed population. Such a result might be 
anticipated if equilibration of adriamycin occurs, but 
the rate of extrusion of adriamycin required to protect 
both populations exceeds the capacity of the P- 
glycoprotein pump in the resistant cells. To identify 
the individual response of the two cell populations in 
mixed culture, it is necessary to mark the cells in some 
way and this is discussed in the following section.
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4.3.4. Genetic marking with B-galactosidase
4.3.4.1. Introduction
In order to assess the individual chemosensitivity of two 
cell types following a period of mixed culture, some 
means of marking the cells is required to permit their 
subsequent identification. Although the work of Bradford 
et al. (1986) had suggested some interaction between
vinca alkaloid sensitive and resistant mouse glioma 
cells, this was based on the overall population response 
and their findings could also have been explained by an 
overgrowth of the resistant line.
Tofilon et al. (1984, 1987) overcame this limitation by
their use of the extent of drug induced sister chromatid 
exchanges (SCE) in rat brain tumour cell lines as a means 
of identification of individual cell lines as well as of 
their drug response. They reported that the sensitive 
and resistant cell populations could be clearly 
delineated by the reduced induction of SCEs in the 
resistant compared to the sensitive line.
An ideal cell lineage marker should be stable, should not 
be diluted by cell division or spread to non-sibling 
cells and should allow easy identification of marked 
cells. Genetic markers can fulfill all these criteria 
and one such marker which has received considerable 
attention in recent years is the E. coli B-galactosidase
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(6-gal) gene. The presence of the 6-gal enzyme allows 
histochemical identification of the marked cell line and 
has been used to examine cell lineages in developmental 
studies in vivo (Sanes, Rubinstein and Nicolas, 1986; 
Price, Turner and Cepko, 1987; Turner and Cepko, 1987). 
These studies have used a recombinant retroviral vector 
system for gene transfer which in general has the 
advantage of greater efficiency of transfer in comparison 
to tranfection techniques (Gilboa, 1986). The use of 
this system for marking of the CH0-K1 and Adrr cell lines 
was therefore investigated.
4.3.4.2. Retroviral infection
Two retroviral producer cell lines were employed in 
retroviral infection studies. virus-containing
supernatant from the ecotropic producer line G4-12.2-YZ 
(Price, Turner and Cepko, 1987) and from the amphotropic 
line PZ NCI (Brown and Mee, unpublished) were used for 
infection of both CH0-K1 and Adrr cell lines. The 
inclusion of the neo gene conferring resistance to G418 
was used for selection of infected lines.
On transfer of the cell lines to selective medium 
containing 0.8mg/ml G418 following the infection 
procedure only CH0-K1 cells from the cultures infected 
with supernatant from G4-12.2-YZ producer line survived 
and grew. All CH0-K1 cultures infected with PZ NCI 
supernatant and Adrr cells infected by either vector
110
failed to survive the selection procedure. Despite 
growth of the one surviving G4-12.2-YZ infected CH0-K1 
line for three weeks in selective medium, subsequent 
staining of this cell line for 6-gal was negative.
4.3.4.3. G418 titration
As it was possible that the concentration of G418 
employed was insufficient for selection and the negative 
6-gal staining in the above studies resulted from 
survival of uninfected cells, the effect of a range of 
G418 concentrations on plating efficiency of CH0-K1 and 
Adrr cells was assessed (table 7). At 0.8 and 1.6mg/ml 
G418 no colonies > 50 cells were produced, although a few 
smaller aggregations of cells were visible at the lower 
concentration. It therefore appeared that although 
0 .8mg/ml was effective in suppressing clonogenic growth 
of CHO-K1 and Adrr cells, the possibility that some 
normal, uninfected cells might survive G418 selection 
could not be excluded. In subsequent experiments 1.2mg/ml 
G418 was accordingly employed in selection.
Once more, however, all cells transferred to selective 
medium failed to survive and grow. Thus virus-containing 
supernatant from amphotropic and ecotropic producer cell 
lines failed to successfully infect either CHO-K1 or Adrr 
cell lines, possibly because of a lack of suitable 
receptor on the CHO lines.
Ill
G418 (mg/ml)
Survival 
CH0-K1 Adriamycin
0.1 98 89
0.2 86 71
0.4 31 62
00o 0 0
1.6 0 0
Table 7
Effect of G418 concentration on survival of CH0-K1 and 
Adrr
9 . 9  ■ •2 x 10 cells were seeded into 25cm flasks containing 
5ml medium with serial dilutions of G418. One flask 
contained medium alone and acted as control. Flasks were 
incubated at 37°C for 7-10 days, then medium removed, 
fixed in methanol, stained with Giemsa and colonies > 50 
cells counted. Survival expressed as a percentage of 
control.
Further attempts to transfer the gene were therefore 
investigated using the technique of DNA transfection.
4.3.4.4. DNA transfection
Two different recombinant vectors each containing 6-gal 
and neo were studied, BAG (Price, Turner and Cepko, 1987) 
and pLGV^ (Debenham and Thacker, unpublished), and used 
for transfection of CH0-K1 and Adrr (section 2.5.4.1.). 
On this occasion, there was survival on G418 selection, 
although at very low frequency (approximately 1-2 
colonies per dish), of both cell lines following 
transfection with each vector. After 2-3 weeks growth in 
selective medium the 6-gal activity of the cell lines was 
assessed by histochemical staining (section 2 .5.4.4.).
CH0-K1 cells transfected with either vector showed 
positive staining, although the extent varied between 10 
and almost 100% of cells in each. The proportion of 
cells staining positively was highest in those cells 
transfected with pLGV^ vector where staining was 
consistently > 90%, and this cell line (designated CHO- 
Kl-BG) was used in all subsequent coculture experiments.
CH0-K1-BG was maintained in selective medium for routine 
culture before transfer to non-selective medium for 
experiments. This continued selection was necessary for 
and successful in the maintainance of the 6-gal 
phenotype. There was some evidence of increased
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stability with continued culture (section 4.3.5.5.). The 
remaining instability of some of the transfected cells in 
the absence of selection was demonstrated by the loss of 
6-gal expression in a proportion of cells within 
individual colonies examined during the course of 
clonogenic assays (section 4.3.5.1.).
None of Adrr cells showed positive staining despite 
survival of G418 selection and were not studied further.
4.3.4.5. Characteristics of CH0-K1-BG cell line
It was important to establish whether insertion of the 
pLGVi genome into the parent cell line CH0-K1 to produce 
the marked cell line CH0-K1-BG produced any alterations 
in the growth properties or chemosensitivity of the 
cells. A clonogenic assay was therefore performed to 
compare the response of the parent and marked lines to 
adriamycin.
The resulting survival curves (fig 13) show the two lines 
have similar responses, although the ID50 of CH0-K1-BG at 
92nM is slightly less than that of the parent line at 
134nM.
Comparison of the growth curves of the two cell lines and 
of those of Adrr and ADR-6 (fig. 14), show the growth 
properties CH0-K1 and CH0-K1-BG to again be very similar,
Figure 13
CHO chemosensitivity: comparison of CH0-K1 and CHO-K1-BG
105 cells/well were added to a 24 well plate and 
incubated at 37°C for 24 hours, then the medium was 
replaced with fresh medium containing serial dilutions of 
drug. Following a further 24 hours incubation, the 
medium and drug were removed and 200/xl 0.25% trypsin 
solution was added to each well. After 10 minutes 
incubation, 1.8ml/well of medium was added and the cells 
separated to a single cell suspension by repeated 
pipetting, then counted on a Coulter counter and 5 x 102 
cells/well were plated into triplicate 60mm petri dishes, 
incubated for 7 days and then stained with 10% Giemsa. 
Colonies > 50 cells were counted and their survival 
expressed as a percentage relative to control wells 
without drug.
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Figure 14
Growth curves of CHO lines
10 cells were plated into 35mm dishes and incubated at 
37°C. The total cell number per dish was estimated at 
regular intervals by trypsinisation of paired dishes at 
each time point and counting the resulting single cell 
suspension on a coulter counter. After the third day of 
growth the medium was replenished every 24 hours.
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with doubling times of 12.6 and 13.8 hours respectively. 
The MDR line Adrr had a doubling time of 16.2 hours, 
whereas that of the hypersensitive line ADR-6 was 18.6 
hours. These growth rates of CH0-K1 , Adrr and ADR-6 are 
comparable to those reported by the Newcastle group 
(I.Hickson, personal communication).
It was therefore concluded that transfection of the 
marker gene had no major effect on either the growth or 
adriamycin sensitivity of CHO-K1. In particular the 
chemosensitivity of the two lines was sufficiently close 
to allow substitution of the marked line CH0-K1-BG for 
the parental line in planned mixed culture experiments.
4.3.5. Coculture studies with marked lines
4.3.5.1. Rationale of technique
To identify the individual response of the two cell lines 
in mixed culture, a standard clonogenic assay was 
performed (section 2.5.5.) using three sets of wells, the 
first containing CH0-K1-BG, the second containing a more 
resistant line (Adrr) or more sensitive line (ADR-6), and 
a third containing a 50:50 mixture of the two cell lines.
Following drug exposure, plating of cells from the first 
two sets of wells allowed growth of colonies which could 
be counted to produce survival curves in standard 
fashion. After growth of colonies from the mixed wells,
the cells were stained histochemically for B-gal (section
2 .5.4.4.) which produced a blue stain, rendering marked 
colonies readily identifiable. The intensity of stain 
varied considerably between colonies. In many colonies 
every cell within that colony showed clear B-gal 
staining, but in others only a proportion of cells within 
the colony did so, possibly because the nine days growth 
of the cells in non selective medium over the course of 
the assay allowed survival of any cells which had lost 
the marker and selective genes.
As any colony which contained even a small proportion of 
positively staining cells was derived, in whole or in 
part, from the CH0-K1-BG cell line, all colonies 
containing positively staining cells were scored as 
"blue” colonies. The number of "blue" and "white" 
(unstained) colonies arising from the mixed wells could 
therefore be counted separately (fig 15) and individual 
survival curves for the two cell populations derived. 
The counts of blue and white colonies could also be 
summed to produce an overall survival curve for the mixed 
wells.
As a control, the colonies arising from wells containg 
CH0-K1-BG alone were also stained for B-gal. These 
showed a similar range of staining intensity and 
frequency within the individual colonies. In addition it 
was established that a small proportion of these colonies 
failed to show any B-gal staining and in mixed culture
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Figure 15
B-galactosidase as a lineage marker in coculture studies
(a) In dishes derived from mixed wells, colonies 
staining positively (blue) and negatively (white) for B- 
gal can be clearly distinguished; (b) variability of B- 
gal expression within individual colony.
(b)
would therefore be counted as a white colony and would be 
erroneously attributed to the unmarked lineage. In a 
series of six experiments the percentage of positive 
staining of CH0-K1-BG colonies varied from 97.9 to 99.3% 
suggesting that the error was small enough not to 
significantly to reduce the validity of this technique.
4.3.5.2. Monolayer coculture: adriamycin
Survival curves following adriamycin exposure of CH0-K1- 
BG alone, Adrr alone and a 50:50 mixture of the two cell 
types were generated (fig.16). The curves for CHO-K1-BG 
and Adrr are clearly separated, confirming their 
differing chemosensitivity. Following exposure to 295 
and 1472nM adriamycin the survival of Adrr is almost 
unaffected, whereas that of CH0-K1-BG is reduced to less 
than 1% of control at the lower drug concentration, with 
no survival at the higher concentration.
The overall survival of the 50:50 mixture shows 
intermediate values, but by separately counting blue and 
white colonies following B-gal staining the survival 
curves for the individual cell lines within •this mixed 
culture can be obtained. The survival of blue colonies 
from the mixed culture is similar to that of CHO-K1-BG, 
with no survival at 295nM adriamycin and above. In 
contrast the curve of white colonies shows apparent 
increased survival at intermediate drug concentrations,
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Figure 16
Coculture of CH0-K1-BG and Adrr : monolayer clonogenic
assay, adriamycin
105 cells/well (CH0-K1-BG alone, Adrr alone or a 50:50 
mixture of the two cell types (mixed)) were added to a 24 
well plate and incubated at 37°C for 24 hours, then the 
medium was replaced with fresh medium containing serial 
dilutions of drug. Following a further 24 hours 
incubation, the medium and drug were removed and 200/xl 
0.25% trypsin solution was added to each well. After 10 
minutes incubation 1.8ml/well of medium was added and the 
cells separated to a single cell suspension by repeated 
pipetting, then counted on a Coulter counter and 5 x 102 
cells/well were plated into triplicate 60mm petri dishes, 
incubated for 7 days and then stained for B-galactosidase 
(section 2.5.4.4.). Colonies > 50 cells were counted and 
their survival expressed as a percentage relative to 
control wells without drug. In dishes derived from mixed 
wells, colonies staining positively (blue) and negatively 
(white) for 6-gal were also counted separately. Points 
represent the mean (+/- SEM) of 6 dishes from 2 separate 
experiments. Error bars omitted if dimensions less than 
that of symbols.
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with survival falling again only at the highest 
concentration.
The shape of this latter curve can be explained by 
consideration of the methodology involved. Following 24 
hour drug exposure the number of surviving cells in each 
well are counted and 5 x 102 cells from each well plated 
into dishes for colony formation. At these drug 
concentrations the survival and growth of CH0-K1-BG is 
reduced in comparison to Adrr (fig. 17) as shown by the 
lower cell count following drug exposure. Thus in mixed 
wells, in the presence of drug, the proportion (and 
absolute number) of Adrr in cells plated out is increased 
compared to control wells without drug, resulting in the 
apparent increase in Adrr survival at these 
concentrations.
The corollary of this is that a corresponding apparent 
reduction in survival of CH0-K1-BG cells at these drug 
concentrations would be expected. As their clonogenic 
survival was virtually zero at this point, the influence 
of this factor on the survival curve is minimal.
Therefore, in summary, the use of a 24 hour period of 
drug exposure allows differential growth of the two cell 
types in the presence of drug which limits the accuracy 
of the derived survival curve of the more resistant cell 
line in mixed culture. However, the survival curve of 
the more sensitive line is relatively unaffected and its
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Figure 17
Coculture of CH0-K1-BG and Adrr : cell counts after 24
hour drug exposure
105 cells/well (CHO-K1-BG alone, Adrr alone or a 50:50 
mixture of the two cell types (mixed)) were added to a 24 
well plate and incubated at 37°C for 24 hours, then the 
medium was replaced with fresh medium containing serial 
dilutions of drug. Following a further 24 hours 
incubation, the medium and drug were removed and 200/xl 
0.25% trypsin solution was added to each well. After 10 
minutes incubation 1.8ml/well of medium was added and the 
cells separated to a single cell suspension by repeated 
pipetting, then counted on a Coulter counter. Cell 
number expressed as a percentage relative to control 
wells without drug.
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close similarity to that of CH0-K1-BG alone is indicative 
of the absence of interaction between the two lines with 
respect to chemosensitivity.
4.3.5.3. Monolayer coculture: mitozantrone
Further experiments were performed with the 
anthracenedione, mitozantrone, to which Adrr is cross- 
resistant, to determine whether there was any evidence of 
interaction between CH0-K1-BG and Adrr with respect to 
mitozantrone chemosensitivity.
The pattern of survival curves obtained following 24 hour 
drug exposure (fig.18) shows a close similarity to that 
of adriamycin (fig.16). The curves for CH0-K1-BG and 
Adrr are widely separated showing a marked difference in 
chemosensitivity, whilst the overall survival of the 
50:50 mixture had intermediate values.
When counted individually, the survival of blue colonies 
from the mixed culture closely parallels that of CH0-K1- 
BG alone, and there is again an apparent increase in 
survival of white colonies at intermediate drug 
concentrations. There was therefore no evidence of 
transfer of mitozantrone resistance between the two cell 
lines.
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Figure 18
Coculture of CH0-K1-BG and Adrr : monolayer clonogenic
assay, mitozantrone
Method identical to that described for figure 16.
Survival expressed as a percentage relative to control 
wells without drug. In dishes derived from mixed wells
colonies staining positively (blue) and negatively 
(white) for 6-gal were also counted separately. Points 
represent the mean of 6 dishes from 2 separate
experiments. Error bars omitted for clarity as
dimensions of majority less than those of symbols.
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4.3.5.4. Monolayer coculture: vincristine
As the above studies with adriamycin and mitozantrone had 
shown no evidence of resistance transfer between Adrr and 
CH0-K1-BG, it was decided to investigate whether such an 
interaction was present when CH0-K1-BG and the drug-
hypersensitive cell line ADR-6 were combined in mixed 
culture. For these studies it was necessary to use a 
third drug from the MDR group, vincristine.
ADR-6 had previously been found to be only 5-fold more 
sensitive to adriamycin than CH0-K1, but to be
approximately 12-fold more sensitive to vincristine 
(I.Hickman, unpublished data). In order to clearly 
detect any interaction between the cell lines it is 
desirable that the magnitude of the chemosensitivity 
difference and therefore the separation of survival
curves is as great as possible. For these experiments 
with vincristine, ADR-6 is therefore the "sensitive" cell 
line and CH0-K1-BG is now the more resistant of the two 
cell lines in mixed culture.
The resulting survival curves show the difference in 
chemosensitivity between the two lines when cultured 
individually to be smaller than that predicted, with the 
IC50 of CH0-K1-BG being less than twice that of ADR-6 
(fig.19). At a vincristine concentration of lOOng/ml
however there is a clear separation between the two 
survival curves, with a 50% survival of CH0-K1-BG
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Figure 19
Coculture of CH0-K1-BG and ADR-6: monolayer clonogenic
assay, vincristine
Method identical to that described for figure 15 except 
that wells contained either CH0-K1-BG alone, ADR-6 alone 
or a 50:50 mixture of the two cell types (mixed). 
Survival expressed as a percentage relative to control 
wells without drug. In dishes derived from mixed wells 
colonies staining positively (blue) and negatively 
(white) for B-gal were also counted separately. Points 
represent mean of 6 dishes from 2 separate experiments. 
Error bars omitted for clarity.
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compared to a 17% survival of ADR-6 . The overall 
survival of the mixed population has an intermediate 
value (33%) . When the number of blue and white colonies 
are counted separately, however, their respective 
survival is virtually identical to that of CHO-K1-BG and 
ADR-6 alone. There is again, therefore, no evidence of 
interaction between the two cell types under these 
conditions.
4.3.5.5. Spheroid coculture
4.3.5.5.1. Introduction
In view of the absence of interaction between the cell 
lines in monolayer culture, and in order to ascertain 
whether the increased intercellular contact provided by 
three dimensional culture is a necessary condition for 
interaction to be manifest, culture of CH0-K1-BG and Adrr 
as multicellular spheroids was established (section
2.5.6.).
In comparison with monolayer, spheroid culture was 
associated with additional complications which had to be 
considered in the design of coculture studies. As 
culture as spheroids entailed growth of cells for six 
days between spheroid initiation and disaggregation for 
clonogenic assay, the differential growth rates of the 
two cell lines would be expected to lead to overgrowth of 
CH0-K1-BG relative to Adrr in mixed spheroid culture. A
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further complication was the difference in the ease with 
which the two cell lines will aggregate and form 
spheroids.
Adrr readily formed relatively compact spheroids, whilst 
CH0-K1-BG tended to produce more irregular aggregations 
with numerous smaller clumps and individual cells. 
Moreover, in initial experiments at least, this longer 
period of growth of CH0-K1-BG cells in non selective 
medium compared to earlier monolayer assays led to loss 
of B-gal activity, so that the percentage of CH0-K1-BG 
colonies which failed to show positive B-gal staining 
increased markedly compared to that seen in the earlier 
monolayer experiments.
In a preliminary experiment, only 88.6% of colonies 
derived from CH0-K1-BG spheroids showed positive B-gal 
staining. Continued passage of the CH0-K1-BG cell line, 
however, appeared to produce increased stability of the 
B-gal phenotype. The experiments described in section 
(4.3.5.5.4.) were performed over the following two months 
and the percentage of positively staining colonies from 
the pure CH0-K1-BG spheroids increased to 99.3%, i.e. to 
a higher value than that seen in earlier monolayer 
studies.
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4.3.5.5.2. Initiation ratio of mixed spheroids
It was thererfore necessary to establish the most 
appropriate ratio of CH0-K1-BG : Adrr to be used in
initiation of mixed spheroids, in order that at the time 
of drug exposure an approximately 50:50 ratio would 
exist. Six day old spheroids initiated from CH0-K1-BG 
cells alone and from varying ratios of CH0-K1-BG : Adrr 
were therefore disaggregated and plated out to allow 
colony growth, and the ratio of blue to white colonies 
calculated following B-gal staining. The results (table 
8) suggest that an initiation ratio of CHO-K1-BG : Adrr 
of between 1:4 and 1:8 would produce approximately equal 
numbers of the two cell types in the resulting mixed 
spheroids, although the results of this assay were again 
complicated at this stage in the work by the low 
percentage of positive B-gal staining in the colonies 
derived from pure CHO-K1-BG spheroids.
On the basis of their growth rate in monolayer culture 
(section 4.3.4.5.) CHO-K1-BG would be expected to undergo 
10.4 divisions in the six days of spheroid growth, 
compared to 8.9 divisions for Adrr , and therefore the 
calculated optimum ratio of CHO-K1-BG : Adrr for spheroid 
initiation would be approximately 1:3. As both the 
calculations based on growth rate and the ratio suggested 
by the above study entail a considerable margin of error, 
a compromise ratio of 1:5 was selected for the subsequent 
mixed spheroid studies.
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Number of colonies
Initiation ratio blue
CH0-K1-BG:Adrr
1:1 285
1:4 527
1:8 335
1:12 83
ratio
white blue:white
67 4.25
329 1.6
347 0.97
311 0.27
Table 8
Effect of initiation ratio of CHO-K1-BG:Adrr on 
composition of mixed spheroids
Six day old spheroids were prepared from CHO-K1-BG cells 
alone and from ratios of CH0-K1-BG : Adrr of 1:1, 1:4,
1:8 and 1:12. Ten spheroids from each group were 
transferred to one well of a 24 well microtitration 
plate. 0.5ml of 0.25% trypsin solution was then added to 
each well and the plate was incubated at 37°C for 10 
minutes. The spheroids were disaggregated to a single 
cell suspension by repeated pipetting and 1.5ml/well of 
medium added. 50/xl aliquots of this suspension were then 
added in triplicate to new 60mm dishes, incubated for 7 
days then fixed and stained for 13-gal (section 2.5.4.4.) 
and the number of colonies > 50 cells staining positively 
(blue) and negatively (white) for B-gal were counted 
separately. Figures represent the mean of 3 dishes.
4.3.5.5.3. Confirmation of heterogeneity within
individual spheroids
In addition to compensating for the differential growth 
rate of CH0-K1-BG and Adrr in mixed spheroids, it was 
also necessary to confirm that each individual spheroid 
consisted of an approximately equal mixture of the two 
cell types, and that following spheroid initiation the 
cells did not preferentially form relatively homologous 
spheroids consisting exclusively or predominantly of a 
single cell type. If the "mixed” spheroid flask 
contained two separate populations of relatively pure 
CH0-K1-BG or pure Adrr spheroids then the potential for 
interaction would be severely limited.
To investigate this possibility "mixed” spheroids 
initiated from a 1:5 ratio of CH0-K1-BG : Adrr were
disaggregated individually and plated out to allow colony 
growth. Following B-gal staining the number of blue and 
white colonies were counted separately. In a series of 
10 spheroids of differing sizes (table 9), the percentage 
of blue colonies varied from 31-64% with a mean value of 
48.4%, confiming that the mixed spheroids examined 
contained approximately equivalent numbers of the two 
cell types. The mean value also confirms that selection 
of the 1:5 ratio of CH0-K1-BG : Adrr used in spheroid
initiation was appropriate and succeeded in compensating 
for the differential growth rate of the two cell lines.
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Number of colonies
Spheroid blue white % blue
1 58 45 56.3
2 109 96 53.2
3 16 9 64.0
4 37 49 43.0
5 68 78 46.6
6 35 32 52.2
7 39 40 49.4
8 38 59 39.2
9 20 44 31.2
10 86 88 49.4
Table 9
Confirmation of heterogeneity within individual spheroids
Ten 6 day old spheroids initiated from a 1:5 ratio of 
CH0-K1-BG:Adrr were each transferred to a single well of 
a 24 well dish. 0.5ml of 0.25% trypsin solution was then 
added to each well and the dish was incubated at 37°C for 
10 minutes. The spheroids were disaggregated to a single 
cell suspension by repeated pipetting and 1.5ml/well of 
medium added. 200/xl aliquots from each well were then 
added to new 60mm dishes, incubated for 7 days, then 
fixed and stained for B-gal (section 2.5.4.4.) and the 
number of colonies > 50 cells staining positively (blue) 
and negatively (white) for B-gal were counted separately.
4.3.5.5.4. Mixed spheroid clonogenic assay: adriamycin
A standard clonogenic assay was performed following 
adriamycin exposure of three sets of spheroids: one
initiated from CHO-K1-BG cells alone, one from Adrr cells 
alone and one from a 1:5 mixture of CH0-K1-BG and Adrr . 
As before, B-gal staining of the resulting colonies 
allowed identification of the individual survival of the 
two cell types from mixed spheroids. As in monolayer 
culture, the survival of Adrr was substantially greater 
than that of CH0-K1-BG, whereas mixed spheroids showed 
intermediate survival (table 10).
When the survival of blue colonies from the mixed 
spheroids was assessed separately, however, this 
parallelled that of CHO-K1-BG alone. Similarly the 
survival of white colonies was comparable to that of Adrr 
alone. In summary, therefore, there was no evidence from 
these studies that three dimensional culture of CHO-K1-BG 
and Adrr in mixed spheroids produces any interaction 
leading to an alteration in the distinct adriamycin 
sensitivity of the two lines.
4.3.6. Gap junctional communication between CHO cells
4.3.6.1. Introduction
Intercellular communication via gap junctions has been 
reported to occur between CHO cells (Weiner and
Survival (%)
2/jlM adriamycin 10/xM adriamycin
CH0-K1-BG 11 0
Adrr 89 55
mixed 38 32
blue 1 0
white 66 56
Table 10
Coculture of CH0-K1-BG and Adrr : Spheroid clonogenic
assay
5 x 105 cells were seeded into base coated flasks: CHO- 
Kl-BG alone, Adrr alone or a 1:5 mixture of the two cell 
types. After 5 days incubation at 37°C, 1.25ml medium
containing serial adriamycin dilutions was added to each 
flask, and after a further 24 hours incubation the medium 
and spheroids from each flask were transferred to 60mm 
dishes and 10 spheroids from each dish were then 
transferred to one well of a 24 well plate. 0.5ml of 
0.25% trypsin solution was then added to each well and 
the dish was incubated at 37°C for 10 minutes. The 
spheroids were disaggregated to a single cell suspension 
by repeated pipetting and 1.5ml of medium added. 20/zl 
aliquots of this suspension were then added in triplicate 
to new 60mm dishes and incubated for 7 days, then fixed 
and stained for B-gal (section 2 .5.4.4.) and the number 
of colonies > 50 cells were counted and expressed as a 
percentage of control in the absence of drug. In those 
dishes derived from mixed spheroids, colonies staining 
positively (blue) and negatively (white) for B-gal were 
counted separately.
Lowenstein, 1983). For the purposes of the present study 
it was however necessary to confirm that communication 
could be demonstrated in both the parent line, CH0-K1, 
and in its variants Adrr , ADR-6 and CH0-K1-BG.
4.3.6.2. Microinjection
Communication was initially assessed in CH0-K1 and Adrr 
by iontophoretic microinjection of Lucifer Yellow into 
individual cells and observation of the extent of dye
spread to neighbouring cells (section 2 .6 .).
The degree of spread observed varied widely between 
individual injections. Following injection of some
cells, no spread was detected over a five minute period 
of observation, whilst with others there was a rapid
passage of dye to all surrounding cells. Of 22 separate 
injections of CH0-K1 cells performed, 15 (68%) produced
spread of dye to two or more contiguous cells indicative 
of functional coupling (gap junctional communication 
could not be inferred from spread to one cell alone, as 
this could arise as a result of incomplete mitotic 
separation). Of 13 separate injections of Adrr cells, 
dye spread to two or more cells was seen on 7 occasions 
(54%).
Comparison of these results with microinjection of L-DAN 
cells, which was one of the best coupled of the human 
NSCLC cell lines on the basis of the nucleotide transfer
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method, is of interest. Dye spread to two or more cells 
was seen following only one of six injections of L-DAN. 
This contrast in percentage coupling values of L-DAN 
cells obtained by nucleotide transfer (table 4) and 
microinjection techniques suggests that nucleotide 
transfer may be the more sensitive of the two methods of 
assessing coupling.
4.3.6.3. Nucleotide transfer
Both homologous and heterologous communication between 
the CHO lines was confirmed by the use of nucleotide 
transfer. Using CH0-K1-BG as donor cells and ADR-6, Adrr 
or CH0-K1-BG itself as recipient cells, examination of 
the resulting autoradiographs showed extensive transfer 
of 3H nucleotides from donor to adjacent recipient cells. 
The extent of nucleotide transfer was not quantified in 
the manner described for NSCLC lines in Chapter 3, 
although the earlier microinjection studies indicated 
that communication in CHO lines was at least as good as 
one of the best coupled NSCLC lines, L-DAN.
In summary, therefore, these studies have confirmed that 
the previously reported gap junctional communication 
between CHO cells (Weiner and Lowenstein, 1983) is 
demonstrable by both microinjection and nucleotide 
transfer techniques in the cell lines used in the present 
study. Gap junctional passage of free small molecules 
would therefore be expected between the cells in mixed
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monolayer and spheroid culture. Consequently poor 
intercellular communication between sensitive and 
resistant cells would not seem to explain the absence of 
interaction observed in mixed culture experiments.
4.4. Passage of adriamycin through gap junctions
4.4.1. Introduction
The model proposed in section 1.7.4. as a mechanism of 
resistance transfer is dependent on the free passage of 
drug from cell to cell through gap junctions along 
diffusion gradients. Thus the P-glycoprotein efflux pump 
in the membrane of an MDR cell could act to regulate the 
cytoplasmic drug concentration both in the MDR cell 
itself and in a sensitive cell to which it is linked by 
gap junctions and thus protect both cells from drug 
induced damage.
The molecular weight exclusion limit for passage through 
mammalian junctions has been calculated to be 
approximately 900 (Flagg-Newton, Simpson and Loewenstein, 
1979) and therefore adriamycin (M.W. 543) and
mitozantrone (M.W. 517.4) should pass without difficulty. 
Vincristine (M.W. 824.9) is close to the exclusion limit, 
where the ease of passage is uncertain and may depend on 
the molecular configuration of the drug. The estimation 
of the exclusion limit is based on the passage of 
fluorescent probes through junctions, and as adriamycin,
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in common with other anthracyclines, displays 
fluorescence it seemed appropriate to exploit this 
property to confirm that drug passage through junctions 
does occur.
4.4.2. Microinj ection
Microinjection of adriamycin into individual BRL cells 
was performed in order to monitor the spread of drug 
associated fluorescence to adjacent cells as described 
with Lucifer Yellow in the preceding section.
As adriamycin is positively charged at physiological pH 
and would therefore require a positive current pulse for 
iontophoresis with consequent depolarisation of the 
injected cell, a positive pressure injection system was 
investigated for adriamycin microinjection although this 
had the disadvantage of entailing a substantial increase 
of perhaps 10-20% in cell volume during the injection 
procedure.
Unfortunately, microinjection of the drug produced 
additional technical and interpretative problems. In a 
series of injections attempting to demonstrate junctional 
spread of adriamycin from the injected cell, it was never 
possible to unequivocally confirm such drug transfer.
This difficulty was attributable to a number of 
disadvantageous features of adriamycin with regard to
microinjection studies. A large number of dyes have been 
investigated for this purpose. Very few are suitable, 
but several characteristics of Lucifer Yellow have led to 
its selection as an agent of choice in the study of gap 
junction mediated dye transfer. In addition to its 
molecular weight these include its intense fluorescence, 
negative charge at physiological pH and inability to 
traverse intact cell membranes. (El Fouly, Trosko and 
Chang, 1987).
Adriamycin is a less satisfactory agent in several
respects. Its fluorescence is much less intense which
complicates adequate monitoring of injections. The 
ability of adriamycin to enter cells by passive diffusion 
across the cell membrane is a further adverse 
characteristic of the drug. During microinjection, 
particularly with the positive pressure system necessary 
for adriamycin, there is a variable amount of leakage of 
dye or drug into the medium bathing the cells. With 
Lucifer Yellow this is not problematic as the dye is
unable to enter the cells by this route. In the case of
adriamycin however there is some direct uptake of drug 
across the cell membrane from the bathing medium. This 
leads to a background level of cellular fluorescence 
which is particularly marked in those cells nearest to 
the injected cell, and which therefore masks the 
detection of any junction mediated spread of drug from 
the injected cell. On the few occasions when
fluorescence was clearly observed in one or more
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neighbouring cells after adriamycin microinjection, 
direct uptake of drug from the medium could not be 
excluded. In view of these problems, it was not possible 
to draw any conclusions about cell-cell transfer of 
adriamycin through gap junctions on the basis of these 
studies.
4.4.3. Scrape loading.
In view of the problems associated with microinjection of 
adriamycin an alternative technique was investigated in 
an attempt to demonstrate junctional transfer of the 
drug.
Scrape loading is a method of promoting cellular uptake 
of dye or other substances by producing a transient tear 
in the plasma membrane, through which the dye can gain 
entry to the cell (McNeil et al. . 1984). If the tear is 
sufficiently small the membrane defect is rapidly 
repaired and there is no loss of cell viability. El 
Fouly, Trosko and Chang (1987) adopted this technique as 
a means of demonstrating gap junctional transfer of 
Lucifer Yellow from scrape loaded cells into contiguous 
cells. In the present experiments, as in their original 
study, the concurrent introduction of a high molecular 
weight dye, rhodamine dextran (M.W. 10,000), which cannot 
traverse gap junctions was also employed. This dye 
remains localised in those membrane-damaged cells at the 
edge of the scrape and permits their identification.
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Following scrape loading of BRL cells with 0.5% Lucifer 
Yellow and 0.1% rhodamine dextran (section 2.7.), uptake 
of both dyes was clearly visible in those cells at the 
edge of the scrape. Spread of lucifer yellow was also 
observed across several cell widths distance from the 
line of scrape, confirming coupling of the cells. When 
scrape loading was attempted with 0.05% adriamycin, 
fluorescence was also most marked in cells at the edge of 
the scrape, but uptake of adriamycin from the medium 
produced background fluorescence in all other cells on 
the coversiip, thus masking any evidence of junctional 
transfer.
Modification of the experimental conditions in an attempt 
to overcome this problem was unsucessful: reduction in
the duration of exposure of the cells to drug containing 
medium did not substantially reduce the background 
fluorescence, and execution of the procedure using ice 
cold medium to increase drug uptake by reducing the rate 
of membrane repair and therefore increase the 
fluorescence intensity of scrape loaded relative to 
background cells also produced no improvement.
In summary, therefore, it was not possible with either 
microinjection or scrape loading techniques to confirm 
whether or not adriamycin can pass through gap junctions. 
A major limitation of both methods was background 
fluorescence secondary to direct diffusion of drug into 
cells from the bathing medium.
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4.5. Discussion
4.5.1. Introduction
Numerous examples have been reported in support of the 
occurence of interaction between phenotypically distinct 
cellular subpopulations (Heppner, Miller and Miller, 
1983). In some cases where the interaction is between 
drug sensitive and resistant subpopulations the mechanism 
underlying this phenomenon is clear, as in the cases of 
transfer of thioguanine sensitivity (Fujimoto et al.. 
1971) or of ouabain resistance (Corsaro and Migeon, 
1977). In other cases the mechanism of interaction 
remains obscure or poorly defined (Miller, Miller and 
Heppner, 1981; Tofilon, Buckley and Deen, 1984; Tofilon, 
Arundel and Dean, 1987).
The rationale for the present study is based upon 
presently available knowledge of the role of the mdrl 
gene and P-glycoprotein as mediators of the MDR 
phenotype. If cellular resistance is dependent on active 
drug efflux from the cell by the P-glycoprotein membrane 
pump then in a pair of sensitive and resistant cells 
coupled by gap junctions, free junctional passage of drug 
between the cells should produce a near-uniform drug 
concentration in each cell. The P-glycoprotein pump in 
the resistant cell would therefore contribute to the 
reduction of intracellular drug concentration, and 
therefore to the resistance, of both cells.
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This study has examined the functional consequences in a 
number of in vitro systems of mixed culture of sensitive 
and MDR CHO cells. For each assay system and each member 
of the MDR group of drugs studied there has been no 
evidence of interaction in the series of experiments 
reported here. The clonogenic assays following genetic 
marking of the parent line to produce CH0-K1-BG would 
have been expected to be particularly sensitive to any 
alterations in chemosensitivity resulting from the 
coculture. The ease of identification of marked colonies 
of the sensitive line CH0-K1-BG and the wide separation 
of the survival curves of CH0-K1-BG and Adrr allowed drug 
concentrations to be selected where there was little or 
no survival of CH0-K1-BG but where the survival of Adrr 
was virtually unaffected. In this situation an increase 
in resistance of a single CH0-K1-BG cell towards of Adrr 
would have been detected by its survival and growth to 
form a blue colony.
4.5.2. Alternative explanations for absence of
interaction
4.5.2.1. Inhomogeneity of cell distribution
One factor which could diminish the potential for 
interaction in these experiments would be preferential 
clustering of the two cell types. If this resulted in a 
non-random distibution of cells and produced discrete 
areas consisting predominantly of a single cell type
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either in monolayer or spheroid, the opportunity for 
heterologous junction formation would clearly be 
restricted.
Such zonal distribution of cellular subpopulations has 
frequently been observed in vitro (Heppner, Miller and 
Miller, 1983) , but the extent of this in the present 
study has not been fully explored. Extensive clustering 
seems unlikely in monolayer in view of the brief period 
of co-culture before drug exposure. In spheroid culture, 
although the precise spatial distribution of cells in the 
intact spheroid was not assessed, the heterogeneous 
composition of individual spheroids was clearly 
confirmed. It was not considered necessary to undertake 
sectioning of spheroids to examine the distribution 
further.
Although mixing of the two cell types may not be optimum 
at all sites, at some locations at least CH0-K1-BG cells 
must be adjacent to and in communication with a number of 
Adrr cells. As discussed above, the assay method should 
have been sufficiently sensitive to demonstrate any 
increase in survival, even if only a small proportion of 
CH0-K1-BG cells came into this category.
4.5.2.2. Duration of cell-cell contact
One further limitation of the clonogenic assay is that 
the two cell types are only in contact before and during
the period of drug exposure. Following this they are 
separated into a single cell suspension and plated out at 
low density to allow colony growth. For the proposed 
model of resistance transfer based on the P-glycoprotein 
efflux mechanism, this arrangement might be expected to 
be adequate for interaction as separation of the two 
populations following drug removal would not interfere 
with this process. If, however, some further mechanism 
such as mutual support of cells with drug induced damage 
by sharing of intermediary metabolites between sensitive 
and resistant cells was necessary for increased survival, 
then continued contact following drug exposure might be 
necessary for optimum limitation of or repair of the 
damage.
As discussed in section 3.4.4. with regard to the NSCLC 
study, a spheroid growth delay assay would allow two 
populations to continue to grow in contact and might be 
considered to offer advantages over the present assay. 
The major limitation of a spheroid growth delay assay, 
however, is that it would only be able to assess the 
overall response of the mixed population and its use 
would forfeit the sensitivity conferred by genetic 
marking with B-gal for identification of the individual 
response of the two populations.
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4.5.2.3. Adequacy of communication
Inadequate gap junctional communication in either the two 
or three dimensional systems studied could also provide 
an explanation for the absence of interaction.
Communication between CHO cells was confirmed in 
monolayer culture by both dye injection and nucleotide 
transfer techniques. There is ample evidence that the 
communication which exists between coupled cells in 
monolayer culture is sufficiently extensive to allow 
functional consequences such as transfer of 6-thioguanine 
or ouabain resistance to be clearly evident (Fujimoto et 
al.. 1971; Corsaro and Migeon, 1977). Some reduction in 
junctional communication in spheroids compared to 
monolayer has been demonstrated in other cell types 
(Dertinger, Hinz and Jacobs, 1982; Sutherland, 1986) but 
the effect of culture of CHO cells in multicellular 
spheroids on their junctional communication relative to 
monolayer was not assessed in the present study.
It seems unlikely, however, that this three dimensional 
arrangement would substantially diminish interaction. 
Miller and colleagues (1990) have recently described, 
using ouabain sensitive and resistant cell lines from a 
mouse mammary tumour growing in three dimensional array 
in collagen gel culture, that a resistant subpopulation 
comprising as little as 5% of the total cell number is
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sufficient for metabolic cooperation and transfer of 
ouabain resistance.
This finding shows that extensive junctional 
communication can exist in three dimensional culture. If 
these results can be extrapolated to spheroid culture, 
they suggest that the potential for metabolic cooperation 
between two populations is sufficiently great so as to be 
unlikely to be affected by zonal distribution or limited 
heterogeneity within individual spheroids. A further 
implication is that if transfer of cytotoxic drug 
resistance within a coupled tumour can occur, then a 
relatively small resistant population within a 
predominately sensitive tumour may have a pronounced 
effect on its drug response.
4.5.2.4. Drug passage between cells
Although the ease of passsage of vincristine through gap 
junctions may be uncertain on the basis of its molecular 
weight, adriamycin and mitozantrone would be expected to 
pass freely, although as it has not been possible to 
confirm this experimentally, some doubt must remain 
regarding these drugs also.
In addition, before the drugs can pass from sensitive to 
resistant cells they must gain free access to the 
cytoplasm of the sensitive cell. If such access is 
associated with either irreversible binding or
irreparable damage to key intracellular sites of action, 
either directly or through free radical generation, 
subsequent passage of drug to the resistant cell would 
have no effect on the extent of damage sustained by the 
sensitive cell.
It is possible that compartmentalisation of intracellular 
adriamycin could reduce the availability of freely 
diffusible drug for junctional passage between cells. In 
addition, such compartmentalisation would restrict the 
capacity of MDR cells to rescue coupled sensitive cells.
Differences have been reported in cellular distribution 
of drug in MDR compared to sensitive cells. In 
adriamycin cytofluorescence studies in colon cancer 
lines, Chauffert et al. (1984) have shown predominantly
nuclear localisation of adriamycin in sensitive cells, 
whereas MDR cells exhibited increased, possibly 
lysosomal, cytoplasmic fluorescence but reduced nuclear 
fluorescence. These observations are consistant with 
increased lysosomal/endosomal trapping of drug in MDR 
cells (Sehested et al., 1987a) reducing drug access to
the nucleus.
If P-glycoprotein-associated drug efflux in MDR cells is 
mediated by drug accumulation in the endosomal 
compartment and subsequent exocytosis (Sehested et al.. 
1987a), it seems likely that this drug efflux mechanism 
would act principally on drugs presenting via the
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extracellular route, and that this mechanism would be 
less suited to dealing with drug delivery into the
cytoplasm via the junctional route. In mixed culture 
such a mechanism would be expected to allow transfer of 
sensitivity rather than of resistance between coupled 
cells, as the drug would gain indirect access to the 
resistant cell cytoplasm from an adjacent sensitive cell 
via the gap junctional route.
No evidence of such transfer was observed in this study 
although, in view of the overshoot in the survival curve 
of the more resistant cells inherent in the assay 
technique, only a relatively large effect would be
evident, and this possibility cannot, therefore, be 
totally discounted.
4.5.2.5. Multiplicity of resistance mechanisms
The CHO cells examined here were selected for study in 
view of the known increased expression of mdrl gene and 
P-glycoprotein in the resistant line Adrr . Further
characterisation of Adrr has since revealed that although 
there is a 5-fold increase in mdrl expression, 2-fold 
increase in drug efflux and 5-fold reduction in drug 
accumulation (assessed with H daunomycm) , it also
exhibits a 4-fold reduction in topoisomerase II (topo II) 
activity compared to the parent line CH0-K1 (I. Hickson, 
personal communication). There is no significant
difference in GST activity between the two lines.
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Thus the chemosensitivity differences of the cell lines 
may not be wholly attributable to their documented 
differences in intracellular drug concentration. If the 
reduction in topo II activity of Adrr has a major 
influence on its chemosensitivity, this form of drug 
resistance seems unlikely to be amenable to transfer to 
adjacent sensitive cells. Those chemosensitivity
differences attributable to topo II should be unaffected 
by intercellular passage of drug between coupled cells. 
Reduction of either levels or activity of the enzyme 
affords fewer opportunities for drug binding to stabilise 
the cleavable complex and produce double strand breaks. 
Thus less damage is sustained by the cell.
It is possible that drug transfer through gap junctions 
and changes in intracellular drug distribution do occur 
as a consequence of mixed culture of CH0-K1-BG and Adrr 
but that such changes have a relatively small role to 
play in their relative drug resistance. If this were the 
case, it could account for the apparent absence of 
interaction in the present study.
Further studies (I. Hickson, personal communication) with 
the hypersensitive line ADR-6 have demonstrated a 
reduction in active drug efflux, even compared to the 
relatively modest levels observed in CH0-K1. The 
contribution of this reduction to the chemosensitivity of 
ADR-6 is not clear. No information is available on the 
mdrl expression of this line.
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The coincidence of multiple and distinct mechanisms of 
resistance in MDR as well as other forms of cytotoxic 
drug resistance is increasingly recognised (Kaye, 1988). 
The presence of several potential mechanisms in Adrr 
complicates its use in the present study. Resistance 
resulting purely from mdrl overexpression (or perhaps 
from alteration in GST activity, where glutathione 
transfer through junctions may play some role) might 
potentially be transferred to a sensitive cell, but this 
would not seem possible in the case of topo II mediated 
resistance, as there seems no clear route through which 
the topo II enzyme activity of one cell can influence the 
activity of another.
Perhaps the ideal model for investigation in the present 
study would have been a cell line whose resistance was 
conferred by transfection of the mdrl gene and where drug 
extrusion by the P-glycoprotein pump was the sole 
mechanism of resistance. It now seems likely, however, 
that tumour resistance in vivo is frequently more 
complex.
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